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ABSTRACT
Bioelectrodynamics is the study of how electromagnetism affects the biophysical
functions of living organisms by examining the effects on biochemical processing at the
cellular level. The Cellular Energy Transfer Science (CETS) system modulates the
magnetic behavior of aqueous metal ions by applying direct current (DC) with a Lorenz
force to a hypotonic saline solution. This treated solution was then used to make growth
media for cancerous and noncancerous cell lines in vitro. Exposure of cancerous and
noncancerous cells to this media showed significant growth inhibition, cell cycle arrest,
hyperpolarization of transmembrane potential and apoptosis of cancerous cells while not
causing a growth inhibition, cell cycle arrest or apoptosis of the noncancerous cell lines.
Microarray and RT-qPCR show the cancerous cells headed to apoptosis by the unfolded
protein response (UPR), TNF/TRAIL, and p53 oncogene activation. Alternatively, the
noncancerous cells show a significant increase in cell migration/wound healing after
exposure to the treated media with no activation of apoptosis pathways.
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CHAPTER 1.

INTRODUCTION

BACKGROUND
Eight years ago I visited a day spa where I had my first experience with a
footbath. This footbath was recommended to me by another colleague due to the effects
she had experienced from this experience. The footbath lasted 30 minutes and when I left
that day, I experienced decreased joint pain, increased stamina and many other noticeable
health improvements. This one experience catapulted me into a journey I could have
never expected. I began to research this device and found many remarkable anecdotal
reports across the globe ranging from increased stamina, decreased joint pain, enhanced
wound healing, cancer treatment symptom relief, improvement in insomnia, improvement
in renal and liver disease, enhanced plant growth and many more. Due to the alternative
nature of this device and the footbaths, I decided it would be best to initially quantify the
effects at the cellular/molecular level. I then approached Dr. Michael A. Whitt, Professor
and Chair of the Department of Microbiology, Immunology and Biochemistry at the
University of Tennessee Health Science Center and began to pursue my Ph.D. which
began this experimental testing of this footbath device we named the Cellular Energy
Transfer Science (CETS) system.
Initially, my goal was to establish that this device/footbaths would not cause harm
to cells or organisms. Due to the anecdotal reports of enhanced plant growth when plants
were watered with water that had been treated by the CETS system, we decided to
conduct an initial pilot experiment with plants to see if we would notice any difference in
plants watered with the CETS treated water versus plants watered with the control
(untreated) water. This initial plant experiment showed significant health differences
between the control and treated groups so we decided to move on to and design in vitro
experiments. Dr. Whitt suggested we begin testing with cancer cells and he provided a
mice melanoma cell line (B16 cells) to begin our controlled in vitro experiments. We
initially had no idea if there would be any measurable effects on the growth of these
cancer cells and we were surprised when a significant growth inhibition was noted with
the B16 cells that were grown in the media that was reconstituted with the CETS system
treated water. These experiments were repeated several times and then it was decided we
should test a noncancerous cell line to see if there was a growth inhibition of these cells.
The CETS treated water did not cause a significant growth inhibition in the noncancerous
cells (L929 cells-mouse fibroblasts). These unexpected findings peaked our interests and
we decided to further pursue this body of work in order to hopefully establish the
mechanisms behind these results.
The objectives/aims that we began to pursue with regards to cancerous and
noncancerous cells were as follows:
1. To examine whether the electromagnetic field generated by the CETS system
differentially affects the growth of cancerous and noncancerous cell lines in vitro.
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2. To determine if cancerous cells showing a significant growth inhibition following
treatment with CETS were displaying an arrest in a specific phase of the cell cycle.
3. To determine differential effects of treated media and treated water at different time
intervals on the cell growth of cancerous and noncancerous cell lines.
4. To quantify and visualize how quickly the cancerous cells ceased to undergo mitosis
following treatment with CETS with tubulin staining.
5. To determine if an increase in mRNA following treatment with CETS in human
cancerous cell line corresponds to an increase in protein production in the treated
cells.
6. To determine if any real time genomic changes could be measured following
treatment with CETS in the human cancerous and noncancerous cell lines.
7. To determine if a form of cell death is occurring after treatment with the CETS in the
cancerous cell lines.
Due to the anecdotal reports of enhanced wound healing across the globe with the
CETS system, the objective/aim we pursued with regards to cell migration in fibroblasts
was:
8. To determine if cell migration is affected after treatment with the CETS in a
noncancerous/fibroblast cell line.
Since the CETS system treated water was showing significant experimental
effects, the objectives/aims we pursued with analyses of the water were:
9. To determine the mechanisms that may be occurring in the water that could explain
significant effects noted.
10. To conduct pre-treatment and post-treatment aqueous metal ion analyses with water
treated by the CETS.
BIOELECTRODYNAMICS
In order to understand how we might begin to study and explain these observed
experimental effects, we began to look at the concepts of bioelectrodynamics. The subject
of bioelectrodynamics is an interdisciplinary subject that has exhibited a rebirth in
medical science and seeks to understand and identify the important roles that
electromagnetism plays in biology and the biophysical function of all living organisms.1
The existence of electrical signals in plants, animals and humans was discovered
centuries ago.2 These electrical signals play important roles in the development,
physiology, regeneration and pathology of cells.3 In recent decades, scientists have come
to view these phenomena to be the result of some action rather than the mediator of cell
physiology and have begun to see the comprehensive link between cell biology and
bioelectricity.4 Currently in Western medicine we utilize electromagnetic signals in
diagnostics and in the treatment for chronic disease in limited applications. The
electrocardiogram and the electroencephalogram are used to record dynamic extracellular
electrical signals of the heart and brain. Electrical stimulation devices such as cardiac
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pacemakers, defibrillators, bone growth stimulators and TENS units are currently used
for treatments of health issues. Science appears to accept these dynamic electrical signals
but reject the little known and understood coexisting steady electrical signals of most
other non-excitable cells. Many electrical-based therapies in the past were considered
fraudulent and viewed with much skepticism. Western medicine currently uses the
investigation and alteration of the biochemical signaling side of the cell through research
on and use of pharmaceuticals, but in the last decade the scientific literature has begun to
address the role that electromagnetism could play in treating health issues.4
Newtonian versus Quantum Physics
Prior to the beginning of the 20th century, science embraced Newtonian physics as
the basis for life processes.6 Concepts based in Newtonian physics refer to the
organizational structure of matter in which the smallest known particle, the atom, consists
of protons, neutrons and electrons. Western practitioners believed that all things could be
divided into parts of the whole. This emphasis on particle theory led to the belief that if
you could affect one particle or pathway of the cell/atom that has gone awry, health could
be restored. This became the basis for the pharmaceutical industry explosion and
development of small molecules (medications) that affected specific cell signaling
pathways normally controlled by the binding of hormones, cytokines, growth factors,
ions, messengers etc., to their cognate receptors.
Alternative views of how energy and health are related with regards to quantum
physics was first recognized by Chinese practitioners thousands of years ago.7 They
realized that when the measurable energy fields of an organism are strong, the organism
remains healthy; when it is weak the organism becomes vulnerable to sickness and
ultimately death. Quantum physicists suggested that “atoms” or matter are actually
energy fields that are constantly spinning, moving or vibrating.6,8,9 The concept that
energy and matter are one in the same was recognized and described by Max Planck who
is considered the father of quantum theory.10 He stated that energy € is equal to a constant
(h) multiplied by its frequency (v) or € = hv. Therefore, it is impossible to separate living
organisms into energy and matter since they are coexistent and it stands to reason that we
should consider and not ignore the role that energy and its associated energy fields can
play in affecting living matter (organisms).
Bioelectrodynamics recognizes that living organisms are energetic beings and
each have individuality that is based in the make-up of its subatomic particles but there is
a commonality which resides on the energy frequency side of their physical composition.
In bioelectrodynamics an organism can be viewed as vibrating fields of energy. An
organism’s DNA sequence defines its constituent physical properties but there is also a
unique frequency or pattern of energy that makes it unique.11
The environment, organism and individual cells are an integration of
interdependent energy fields. Organisms are affected by the energy field of other
organisms around them.12 Flow of energy is information in the quantum world and is
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holistic meaning the whole being and not one specific chemical pathway is involved in
the energy ebb and flow. Since Newtonian physics divides living organisms into
individual parts and targets their cell signaling pathways through the use of biochemical
means, this creates a series of interconnected events that can lead to unwanted upstream
and downstream effects. As one delves into the metabolic processes of the cell, it does
not take long to realize the complicated and multidimensional nature of the cell and how
quickly changes are occurring in multiple pathways simultaneously.13 Energy medicine
has the ability to simultaneously enhance many biological processes that are necessary
for and are the basis of life. Electromagnetic energy fields are absorbed by all excitable
and non-excitable cells in the organism and affect and enhance multiple pathways at the
same.14
Bioelectrodynamics can utilize an electrical energy source that affects not only
the organism but the field immediately surrounding the organism. The tertiary interaction
of these three components: 1) energy source, 2) environment, and the 3) organism are all
involved in the process of bioelectrodynamics. The energy source can consist of
regulated electrical current (alternating current/AC or direct current/DC) delivered
through a specifically designed power pack, natural sources that emit electrical fields
such as lightning, sunlight, cosmic radiation, or other man-made devices such as cellular
phones, microwaves, electrical power lines, televisions, other living organisms and
surrounding objects. The environment is the immediate area surrounding the organism
(cell or individual) such as the extracellular matrix of the cell as well as the energy field
surrounding the organism (person). If electromagnetic fields generated by the energy
source, the organism/cell and the environmental field interact either positively or
negatively, physiologic processes of the living organism can be affected in a quantum or
tertiary fashion.14,15 When an energy emanates from an appropriate source that is
beneficial to the living organism this energy becomes bioenergy and will be utilized and
absorbed by the whole organism to be used for cell physiological processing. Multiple
cell signaling pathways of the whole organism will be affected by an external
electromagnetic energy source in a harmonic vibration with the environment.
Veritable versus Putative Energy Fields
The National Center for Complementary and Integrative Health has divided
energy medicine into veritable applications or those that can be measured for diagnosis
and treatment, and putative applications (biofields), those that have defied measurement
by lack of reproducibility.16 Eastern medicine applications have historically been
considered putative by involving a health practitioner and a client with the practitioner
addressing the electromagnetic fields of the whole living organism through such methods
as acupuncture, reflexology, massage, healing touch, Reiki etc. Putative energy fields
have been the most controversial of the alternative energy medicine practices but they are
gaining popularity in the American marketplace as well as academic medical centers
where 85% of medical schools offer elective courses in these alternative health
practices.16
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Recent veritable research has demonstrated that remarkable effects on the health
of a living organism can be acquired by addressing its electromagnetic field.17 Moreover,
it is known that organisms must process environmental electromagnetic signaling to
survive and these signals are indeed now measurable with recent advances in medical
science.12 The speed of an electromagnetic energy signal is 186,000 miles per second and
the speed of a chemical reaction is less than 1 cm per second.6 This indicates how much
more efficient a holistic electromagnetic signal operates that is based in quantum theory
compared to a chemical signal which is based in Newtonian theory. These new
measurement tools in the field of nanotechnology and the development of veritable
energy medicine applications have the potential to produce significant and reproducible
research findings and clinical results that will offer credible and valid applications in
Western medicine.
LITERATURE REVIEW
We can measure transmembrane potential (Vmem) of cells, a phenomena
resulting from differential ion concentrations across the cell membrane.18,19 We know that
cell behavior is regulated by not only chemical gradients but also by bioelectric cues.12
Vmem differences have been found in cancerous, injured and proliferating cells.19,20
Cancerous, injured and proliferating cells have a more depolarized membrane potential of
approximately < -30mV, while noncancerous cells have a resting potential of > -70mV.19
Cells have been found to respond to different electromagnetic signals when undergoing
division, migration and differentiation.2 Furthermore, scientists have found that
bioelectricity or electromagnetic fields involve the changing gradients of transmembrane
potential, ion channel activity and electromagnetic fields that are produced and sensed by
non-excitable cells in living organisms.1,20,21 Therefore, bioelectricity shows an effect
well beyond excitable cells and has been shown to affect wound healing, cell migration,
nerve growth, limb regeneration and cancer.3,22 Changes in transcription, after
depolarization of the cell membrane, occurs across multiple genes and it appears that
bioelectric cues or signals override chemical signals since human mesenchymal stem
cells will not differentiate without hyperpolarization in spite of potent chemical
inducers.23
Bioelectric gradients have also been found to mediate signaling beyond cell to cell
communication and actually appear to communicate throughout the whole organism and
beyond.12 This suggests that bioelectric cues are a very efficient medium for carrying
information. For example, planarian flatworms can remarkably regenerate themselves
from partial body fragments.24The partial body fragments require communication to
control whether the regrowth occurs symmetrically or asymmetrically where one edge
becomes a head or becomes a tail in order to grow the entire whole organism. The cells
must be able to conduct long-range communication since gap junction (cell-cell)
communication would not suffice for this high level differentiation from the remaining
partial body fragments.25

5

It has also been shown that electrical events tell the cells what to do; voltage
changes have been found to be a sign of cancer as well as determine whether or not
cancer may develop.20 In addition, a research group at Tuft’s University has found that in
addition to cells being regulated by their own internal voltage potential they are also
regulated by surrounding organisms, as well as the environment.12 This finding opens the
door for potential research in the areas of cancer, wound care and any other disease
process that can be attributed to a depolarized Vmem that leads to cell damage,
inflammation, and death.19 The four cardinal signs of inflammation are: redness,
swelling, heat and pain; the fifth cardinal sign of inflammation is loss of function.26 Since
loss of function is thought to originate with inflammation of the cell, Vmem augmentation
with bioelectromagnetic energy could offer a new treatment options for chronic disease.
To test this hypothesis, a single-group open label phase I/II trial was performed to assess
the safety and efficacy of intrabuccal administration of low levels of electromagnetic
fields in patients with advanced hepatocellular carcinoma. The results of this study
indicated that treatment with low levels of 27.12 MHz radiofrequency electromagnetic
fields was associated with a decrease in tumor size that is mediated by genetic expression
as well as increased progression-free survival for > 6 months in the participants.17
DISCUSSION
These in vitro experiments and in vivo human trials demonstrate the potential of
electromagnetic fields as diagnostic tools and as treatments for disease. Now that tools
have been developed that can quantify processes on the cellular level, including the
effects of electromagnetic fields and bioelectricity on living organisms; research on
examining the mechanisms by which cells interact with bioelectrical signals, chemical
gradients and physical forces has begun to emerge.32,33 Subsequently, molecular analysis
of the effects of bioelectricity may point us to a way we can understand the mechanisms
that occurs at the cellular level and lead us to biomedical transformations. The concepts
of bioelectrodynamics gave us a basis for pursuing these in vitro effects from the
application of electromagnetic fields by the CETS system. The methods we adopted were
based on the applications to people, plants and animals that have been used across the
globe for 20 years. In Chapters 2, 3 and 4, we will begin to pursue our aims in order to
quantify in vitro effects that the CETS system treated water has on cancerous and
noncancerous cells. These in vitro experiments may open the door for future applications
of veritable quantum physics in Western medicine.
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CHAPTER 2. HYPERPOLARIZATION OF PLASMA MEMBRANES
THROUGH MAGNETIC MODULATION OF AQUEOUS METAL IONS
INTRODUCTION
Water is the most abundant chemical in all living things and makes up 80% of all
living organisms. Almost two decades ago, a device was invented in Australia that
utilizes 2.5 amperes of direct current (DC) that is applied perpendicularly to a
module/array of copper and stainless steel plates. This device, the Cellular Energy
Transfer Science system (CETS) creates a bio-charge, which can be defined as a form of
organic or bio-electricity, from an artificial energy source that can be applied to living
organisms through a medium of water. The CETS has been widely sold across the globe
in holistic markets and administered in the form of footbaths and baths with reports of
pain relief, increased stamina, improvements in renal and hepatic function, support in
cancer treatment recovery, decreased recovery time from illness and injury and many
other health applications.15 Users of this device immerse part or all of their body in the
water for 20–35 minutes every other day. The device has been approved by the
Therapeutic Goods Administration to be marketed as a therapeutic device in Australia.
The current manufacturer in the United States reports that approximately 15,000 units are
sold yearly with over two million footbaths/baths given worldwide to date since the
invention was marketed (S. Walker, personal communication).
It has been shown that cell behavior is regulated by chemical gradients as well as
bioelectric cues.12 Plasma membrane potential (Vmem) differences which represent these
cues have been found to differ for cancerous, injured and proliferating cells.20,21
Cancerous, injured and proliferating cells have a measurable depolarized membrane
potential of approximately < -30mV, while noncancerous cells have a resting potential of
> -70mV.19 Cells have also been shown to respond to different electromagnetic signals
when undergoing division, migration and differentiation.2 In addition, electromagnetic
fields have been found to induce gradient changes of Vmem that are produced and sensed
by non-excitable cells and in living organisms.20,21 Therefore, bioelectricity has been
shown to induce effects beyond excitable cells and to affect wound healing, cell
migration, nerve growth, limb regeneration and cancer.1,3,22 Due to the interesting
anecdotal testimonials, the therapeutic uses of the CETS system from across the globe,
and the scientific basis for membrane potential differences in cancerous, injured and
proliferating cells; we undertook testing at the molecular level to quantify what, if any,
effects were occurring to drive these widespread claims.
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METHODS
Cells and Cell Culture Medias
Four cell lines were used for this investigation: B16 cells (murine melanoma),
L929 cells (mouse fibroblasts), MDA-MB231 cells (human triple negative breast cancer)
and MCF-10A cells (human breast epithelial cells). The L929, MDA-MB231 and MCF10A cells were obtained from ATCC and the B16 cells from the laboratory of Dr. Larry
Pfeffer (Department of Pathology, UTHSC). The B16, L929 and MDA-MB231 cells
were all cultured in 1X Dulbecco’s Modified Eagles Medium (#D6429) with 10% Fetal
Bovine Serum (DMEM-10) from Atlanta Biologicals. To prepare 1X DMEM, a 10X
DMEM (#D2429) solution was diluted 9:1 with a hypotonic (3mM) saline solution that
had been treated for 30 minutes with the CETS system and filtered through Corning
bottle top cellulose acetate membrane vacuum 0.22 micron filter (CLS430521, Sigma).
The hypotonic saline solution was made using deionized water from the laboratory and a
5M sodium chloride (Molecular Biology grade- #V4221, Lot # 18693201
DNase/RNase/Protease free) solution from Promega Corporation. The medium was
supplemented with the appropriate concentrations of folic acid, 0.004gm/L (SigmaAldrich-F8758-5G, Lot # SLBF 16021), glucose 4000mg/L (Sigma-Aldrich G7021100G, Lot # 071N01455), glutamine 0.584gm/L (Sigma-Aldrich-G7513, Lot #
RNBC5892) and sodium bicarbonate 3.7gm/L (Biowittaker # 15-6131) in order to obtain
the exact concentrations of standard DMEM. Fetal bovine serum was added to the
diluted DMEM to achieve a 10% concentration.
The MCF-10A cells were cultured in DMEM/F12 (Invitrogen #11330-032) with
5% Horse Serum (Invitrogen # 11330-032) that was made by adding EGF,
Hydrocortisone, cholera toxin and insulin. In order to make the treated and control
media, we used DMEM 10X (Sigma-# D2429 diluted 9:1 and F-12 Nutrient Mix powder
(Life technologies # 21700-026) mixed to manufacturer protocol specifications using
either treated or control saline. The diluted DMEM and F-12 media was then mixed 1:1
was filtered through a 0.22 micron filter and then combined with appropriate
concentrations of EGF 20ng/ml (PeproTech 100-47), hydrocortisone 0.5mg/ml (SigmaAldrich #H-0888), cholera toxin 100ng/ml (Sigma-Aldrich #C-8052) and insulin 10
mcg/ml (Sigma-Aldrich #I-1882). Horse serum was then added to obtain a 5%
concentration in the cell culture media.
Cell Growth Studies
We cultured the treated groups of B16, L929 and MDA-MB231 cells in the
DMEM-10 with media that was reconstituted with a hypotonic saline solution that had
been treated with the CETS system for 30 minutes and the control groups of each of the
three cell lines were cultured in media that was reconstituted with the same hypotonic
saline solution prior to treatment with the CETS system. The treated group of MCF-10A
cells was cultured in the DMEM/F12-5 media that had been reconstituted with a
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hypotonic saline solution that had been treated with the CETS system for 30 minutes and
the control group was cultured in media that was reconstituted with a hypotonic saline
solution that had not been treated with the CETS system. On day one, aliquots of 10,000
cells were plated in three 6-well plates for each of the two groups for each of the four cell
lines. They were plated in their standard (non-CETS treated) DMEM-10 or DMEM/F125 media on day 1. On day 2, the treated (n=18) and control (n=18) media for each of the
four cell lines were made and the original standard media was replaced in each of the
wells with the newly prepared treated and control media. On days 3 through 7, wells from
the control group and treated group of each cell lines were trypsinized, removed from 3
wells of each group and counted using a Scepter cell counter (EMD Millipore).
Remaining wells had the control and treated media replaced daily with freshly prepared
treated or control media unless otherwise specified in the figure legends.
Cell Cycle Analyses
Cell cycle analyses were performed with each cell line that were grown in treated
versus control media for three days with the media replaced daily with freshly made
treated or control media. The cells were trypsinized and washed twice with phosphate
buffered saline (PBS) containing 0.1% FBS and subsequently fixed with -20o C ethanol
by adding drop wise to the pellet while vortexing to minimize clumping. After overnight
incubation at 4o C, the cells were washed twice with ice cold PBS by centrifugation at
850g for 5 minutes and re-suspended at a final concentration of 1,000,000/ml in a total
volume of 300 microliters. The cell suspensions were placed in PBS after treating with
DNase free RNase (50 mcl of a 100 mcg/ml stock RNase) to remove all remnants of
RNA and then stained with 200 microliters of propidium iodide (50 microgram/ml stock)
prior to cell cycle flow cytometry. The data were analyzed using ModFit LT software.
Cell Death Assay
Annexin V-FITC Apoptosis Detection Kit (APOAF Sigma-Aldrich) was used to
conduct an apoptosis assay on the murine melanoma and the human breast carcinoma.
After initiating apoptosis, cells translocate the membrane phosphatidylserine (PS) from
the inner face (cytoplasmic side) of the plasma membrane to the cell surface. Once the PS
is on the cell surface from the failure of flippase, it can be easily detected by staining with
a green fluorescent protein, Annexin V that has a high affinity for PS. Propidium iodide
(PI) was also added with this assay to detect the cells that have already undergone
necrosis/cell death. Because PI enters the cell membrane of dead cells, it differentiates
apoptotic from the dead cells. The MDA-MB231 and B16 cells were plated (1 x 106) and
grown in treated and control media in 60mm plates for 3 days before performing the
experiments. They were then typsinized and removed and washed twice in PBS. The
pellet of treated and control cells were then resuspended in 500 mcl of 1x Binding Buffer
at a concentration of 1 x 106 cells/ml. Then 5 mcl of annexin V-FITC and 10 mcl of
propidum iodide were added to the cells. The cells were then analyzed with cell flow
cytometry and microscopy.
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Membrane Potential Analyses
Membrane potential analyses were performed on all four cell lines using FivePhoton Membrane Potential Assay (Five-Photon Biochemical). This assay utilizes a
membrane permeant dye formulation of oxonol dyes for transmembrane potential
measurement. Membrane potential assay dyes enter depolarized cells and bind to their
intracellular membranes or proteins that leads to enhance fluorescence. An increase in
depolarization leads to an elevated influx of the voltage sensitive dye and an increase
fluorescence that can be measured by fluorescent microplate readers or flow cytometers.
After washing twice with PBS to remove serum factors, 60,000 cells were plated in the
wells of a 96-well plate and placed in 100 mcl of serum-free media. The wells were
plated with both the treated and control groups of each cell line. The cells were exposed
to the treated and control serum-free media for the time points of: 45 minutes, 12 hours,
24 hours and 72 hours prior to the addition of 100 mcl External Assay Buffer to make a
1X dye solution and 200 mcl was added to each well. The cells were then incubated in
the dark at 37 degree Celsius in a CO2 incubator for 20 minutes to load the dye prior to
placing in a fluorescent plate reader. The fluorescence was measured in the 530 excitation
\wavelength (nm) and 565 emission wavelength (nm) with a 550 emission cut-off (nm).
The lipophilic, anionic dye partitions across the plasma membrane of live cells and is
dependent on the membrane potential across the membrane. When the cells are
depolarized, more indicator dye enters the cells causing an increase in fluorescence
signal.
BCA Protein Analyses
The MDA-MB231 cells were plated (3 x 10 6) in two 10cm plates and grown in
treated media and control media. Media were change daily until confluence. BCA Protein
Assay Reagent Kit (Pierce 23225 23227) is a detergent-compatible formulation based on
bicinchoninic acid (BCA) for the colorimetric detection of quantitation of total protein
was used for this analysis. This method utilizes a well-known reduction of copper by
protein in an alkaline medium with sensitive and selective colorimetric detection of the
cuprous cation. The cells were trypsinized and pelleted using 500 rpm for 5 minutes,
then lysed in 300 mcl of mammalian cell lysis buffer (Abcam ab179835). Total protein
concentration was determined using the microplate procedure and the dilution parameters
of 0, 200, 400, 600, 800 and 100 micrograms/ml were made according to the preparation
of diluted albumin (BSA) standards with 50 parts of BCA Reagent A with 1 part BCA
Reagent B (50:1, Reagent A:B). Once the dilutions were made, 25 mcl of each standard
and unknown sample replicates were pipetted into the microplate wells. Prior to placing
wells in a 37 degree Celsius incubator for 30 minutes, 200 mcl of the working reagent
was added to each well. The plate was then cooled to room temperature and measured at
the absorbance of 562 nm on a plate reader.
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RT-qPCR Analyses
In order to validate some of the significant genomic effects seen in the microarray
analysis on the MDA-MB231 cells, we conducted Real-Time qPCR using LC 480 and
UPL probes. Ten genes were chosen: (1) CHaC glutathione-specific gammaglutamylcyclotransferase 1 (CHAC1), (2) Endoplasmic Reticulum to Nucleus Signaling 1
(ERN1), (3) Homocysteine-Inducible, Endoplasmic Reticulum Stress-Inducible,
Ubiquitin-Like Domain Member 1 (HERPUD1), (4) Tumor Necrosis Factor Receptor
Family 9 (TNFRSF9), (5) Junction-mediating and regulatory protein of p53 (JMY), (6)
Cyclin E2 (CCNE2), (7) Hyaluronan-mediated motility receptor (HMMR), (8) DNADamage-Inducible Transcipt 3 (DDIT3), (9) Caspase 4 (CASP4), (10) Chloride
Intracellular Channel Protein 4 (CLIC4) and RIBOPROTS19 (housekeeping). The
primers were designed using universal probe library. Transcriptor First Strand cDNA
Synthesis Kit (Roche Cat. No. 04 379 012 001) was used to make cDNA with the original
microarray samples. Then the following reagents were added to the wells in the
appropriate measurements according to the protocol in order to make 8mcl of this master
mix for each well used in the 5-dilution factors (in triplicate) of the cDNA: universal
library probe (UPL probe, Roche) at 10uM, LC480 master mix (2X concentration,
Roche), mixed left and right primers at 10uM each in DNase, RNase & Protease-free
water (Corning cellgro, # 46-000 Cl), and nuclease free water. The five dilutions of
cDNA were: undiluted, 1:10, 1:100, 1:1,000, 1:10,000. The 8 mcl of the master mix and 2
mcl of the cDNA were added to wells of a 96 well plate. The plates were centrifuged and
activated for 5 minutes at 95 degrees. Then there was an amplification of 45 thermal
cycles using 500C for 2 minutes (separation), 950C for 10 minutes (initialization) and
950C for 15 seconds (denaturation), and 600C for 1 minute (annealing), and 70-740C for 5
minutes (elongation). The amplicons were then plotted for validation.
RESULTS
Differential Effects on Cancerous and Noncancerous Cell Growth
Cell growth studies were conducted to examine whether the electromagnetic field
generated by the CETS system differentially affected the growth of cancerous and
noncancerous cells lines in vitro. We observed a significant growth inhibition of doubling
times between control and treated groups of both the murine melanoma and human breast
carcinoma cell lines when maintained in CETS-treated media while there was little to no
growth effect on the noncancerous murine fibroblasts or human breast epithelial cells
(Figure 1). Growth rates and doubling times (Table 1) extracted from this analysis could
then be compared using the Mann-Whitney U-test. This nonparametric test does not
require a normal or Gaussian distribution. The measurements of the growth rate are
independent since each replicate represents a different culture dish. The data were also
log-transformed to fit a linear mixed effects model. Significance between the cancerous
cell control and treated groups was declared with both methods with an alpha of < 0.05.
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Figure 1.
Cell Growth/Time in Control and Treated Media.
~ 10,000 cells were plated in standard media in triplicate for each cell line. Control and
treated media were reconstituted daily with CETS control/treated water and replaced
daily. Wells were counted in triplicate daily with three repeats. Growth rate with MannWhitney U-test (p < 0.05). (A) Murine melanoma-Z-score is 3.4486; p = 0.00056; Uvalue is 52.5; CV-99. (B) Murine fibroblasts-Z-score is 0.4276; p = 0.6672; U-value is
203; data are normal and z-value can be used. (C) Human breast carcinoma –Z-Score is
4.3978; p = 0; U-value is 22.5; CV-99. (D) Human breast epithelial cells-Z-score is0.8701; p = 0.3843; U-value is 134; data are normal and z-value can be used.

12

Table 1.
Doubling Times of the Four Cell Lines Using the Exponential Growth
Equation of the Non-Linear Regression Analysis Function of Prizm GraphPad v
5.04.
Cell Line

Control

Treated

Mouse melanoma (B16-F10)

30.5 hours

> 7 days

Mouse fibroblast (L929)

21.5 hours

21.5 hours

Human breast cancer (MDA-MB-231)

23.0 hours

> 7 days

Human breast epithelium (MCF-10A)

24.6 hours

28.1 hours
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There was no significant difference in the growth rates of the noncancerous cell control
and treated groups with both methods.
We then proceeded to determine how long the effects of the treated water that was
used to reconstitute the growth media would retain the effects that led to the significant
growth inhibition of cancerous cells. The first set of experiments was conducted with
treated water that was made fresh daily to make the growth media that was changed daily
in the wells over 7 days. To determine how long the effect lasted, we treated water with
the CETS system and allowed the treated water to sit for set time periods of 2, 3, 7and 14
days prior to making the treated media which was prepared and changed daily. For
example, in the “2 day old” sample, media was prepared using treated or control dilute
saline beginning 2 days post treatment and the media was prepared daily using the same
solution therefore on days 2-7. We observed a significant growth inhibition of growth in
all samples demonstrating the effect is maintained for up to two weeks after initial
treatment with the CETS system (Figure 2).
Differential Effects on the Cell Size of Cancerous and Noncancerous Cells
Due to the observed microscopic changes in cell morphology that were noted in
the experiments and the fact that cell size is known to decrease when cells undergo
various changes such as cell cycle progression and apoptosis, cell size data was collected
using the Scepter 2.0 Cell Counter (Merck Millipore) and analyzed with unpaired t-tests.
There was a significant difference in cell size between the treated and control groups in
the cancerous cells while no significant difference was detected in the noncancerous cells
lines (Figure 3). The MDA-MB231 cells show the largest significance and the data
suggest that the cell size increases initially in the treated group and begins to decrease or
shrink on day 6 (Figure 4).
Differential Effects on the Cell Growth of Media Made on Day 1 Only
In order to determine if the effects on the growth inhibition of cancer cells
required daily making of replacement media that was made only on day 1 and not made
fresh daily like the original growth experiments, we conducted the experiments by
making growth media on day 1 and used the media made on day one to replace the
control and treated media daily with the murine melanoma and the human breast
carcinoma. After cell counts were conducted until day 7, the effect of growth inhibition
appeared to wear off at around day 6 but the murine melanoma and human breast
carcinoma showed an overall growth inhibition (Figure 5).
Differential Effects on Cell Cycle Progression of Cancerous and Noncancerous Cells
In order to determine if the cancerous cells that were showing a significant growth
inhibition were displaying an arrest in a specific phase of the cell cycle, cell cycle
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Figure 2.
Growth Rate of MDA-MB231 Cells in Media Reconstituted from 2, 3,
7 and 14 Day Old Water.
~10,000 MDA-MB231 cells were plated in standard media and after one day of growth
the standard media was replaced with control or treated media daily. Control and treated
media were made from 2, 3, 7, or 14 day old water and replaced daily. Wells were
counted in triplicate daily from both control and treated groups. MDA-MB231 cell
growth rates using Mann-Whitney U tests (p < 0.05). (A) 2-7 days-Z-score is 3.1164; p =
0.0018; U-value is 63; CV =99. (B) 3-9 days-Z-score is 3.8866; p = .0001; U-value is
65.5; CV= 99. (C) 7-13 days-Z-score 3.3583; p = 0.0078; U value 86.5; CV = 99. (D) 1420 days-Z-score 3.2828; p = 0.00104; U- value is 89.5; CV = 99.
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Figure 3.
B16, L929, MDA-MB231, MCF-10A Cells Size with Sceptor 2.0 Cell
Counter (Merck Millipore).
Cell size was analyzed by counting/analyzing cell size daily while counted in triplicate
for 7 days while treated and control groups of each cell lines were grown in the control
and treated media. The results shown are the means of cell size for days 1-7. Unpaired ttests show a significant difference in cell size between the treated and control groups of
the cancerous B16 and MDA-MB231 cells. There is no significant difference noted
between the noncancerous L929 and MCF-10A cells.
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Figure 4.
MDA-MB231 versus MCF-10A Daily Cell Size Analysis.
When analyzing the daily cell size changes, the MDA-MB231 treated cells (red) show an
increase in cell size on days 1-5 when compared to control (blue) and then appear to have
a drop in cell size on day 6. The MCF-10A cells appear to be larger when initially placed
in the treated (red) and control (blue) media, but overall have uniform size between
control and treated cells from day 1-6.
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Figure 5.
Effect of Storing Media on Cell Growth Inhibition.
Control and treated media for (A) B16 and (B) MDA-MB231 cells were made on day 1
and this media made on day 1 were used to replace the control and treated media daily.
Cells were counted daily in triplicate. B16 Cells cultured in media prepared on Day 1
(media changed daily) unpaired t-tests; mean (C) 656795; mean (T) 186,752.4; p =
0.032002; ts = 2.222029; df = 40. MDA-MB231 cells cultured in media prepared on Day
1 (media changed daily) unpaired t-tests; mean (C) 676232.1; mean (T) 220645.7; p =
0.016367; ts = 2.506314; df = 40.
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analyses were conducted on all four cell lines with cell flow cytometry utilizing ModFit.
When compared to controls, CETS-treated murine melanoma did not enter in S phase and
showed a two-fold increase G0/G1 phase while treated MDA-MB231 cells were halted in
S and G2/M phases were unable to complete mitosis (Figure 6).
Differential Effects of the Modulation of the Magnetic Behavior of Metal Aqueous
Ions on the Mitotic Index of Cancerous Cells
In order to quantify and visualize how quickly and if the cancerous cells ceased to
undergo mitosis, human breast carcinoma cells were grown in control or treated media
for one day. The cells were then fixed and stained with DAPI to visualize the nuclei and
with an anti-tubulin antibody followed by a rhodamine-conjugated secondary antibody.
The untreated control cells had ~17% of the cells undergoing active cell division,
whereas cells grown in the treated media showed some nuclear condensation, but no
detectable mitotic spindle formation (Figure 7).
Effects on the Membrane Potential of Cancerous and Noncancerous Cells
Due to the known Vmem differences in cancerous, injured or proliferating cells,
we decided to conduct membrane potential assays on all four cell lines. We hypothesized
that the treated media would have a differential effect on membrane potential of the
treated versus control cells. Upon analysis of the data, we found that all four cell lines
showed rapid hyperpolarization of the cells when placed in media that occurs in the first
45 minutes. When the cells are hyperpolarized the indicator dye exits the cells, resulting
in a decrease in fluorescence signal. All four cell lines remained hyperpolarized while
maintained in the treated media (Figure 8). Percent differences between the treated and
control groups show the noncancerous cells return closer to baseline at 24 hours posttreatment, while the cancerous cells remain in a more hyperpolarized state (Table 2).
The results indicate that all four cell lines undergo a rapid hyperpolarization and
remain hyperpolarized during maintenance in the treated media. In the microarray
analysis delineated below, gene CLIC4 was upregulated 2.75 times which is a chloride
channel made up of a diverse group of proteins that stabilize cell membrane potential,
trans-epithelial transport, maintenance of intracellular pH and regulation of cell volume.
Differential Effects on Cell Death by Phase and Fluorescent Microscopy
In Figure 9, we left the breast carcinoma growing in treated media for 14 days
and the control cells grew for 5 days until confluence. The treated cells in Figure 9
(right) show the cells rounding up off the bottom as well as cell shrinkage, nuclear
condensation and blebbing when compared to the control cells in Figure 9 (left). Due to
the significant cell growth inhibition, cell cycle arrest and the observed effects of cell
shrinkage (Figure 4), nuclear fragmentation and “blebbing” (Figure 9) we proceeded to
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Figure 6.
Cell Cycle Analysis Using Propidium Iodide and Cell Flow
Cytometry.
A) Treated murine melanoma did not enter in S phase and showed a two-fold increase
G0/G1 phase while treated (B) Treated L929 (C) Treated MDA-MB231 cells were
halted in S and G2/M phases were unable to complete mitosis. (D) Treated MCF-10A
cells had no change in the cell cycle.
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Figure 7.
Tubulin Staining of MDA-MB231 Cells after Growth in Both Control
and Treated Media for One Day.
Cells were fixed and stained with DAPI to visualize the nuclei and with an anti-tubulin
antibody followed by a rhodamine-conjugated secondary antibody. A). The human breast
carcinoma were then grown in control or treated media for one day and were fixed and
stained DAPI to visualize the nuclei and with an anti-tubulin antibody followed by a
rhodamine-conjugated secondary antibody. The untreated control cells (left) had ~17% of
the cells undergoing active cell division (arrows), whereas cells grown in the treated
media (right) showed some nuclear condensation, but no detectable mitotic spindle
formation. B) Higher magnification of A.
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Figure 8.
Membrane Potential Assay.
Percent increase was noted between control and treated groups of MDA-MB231, MCF10A, B16 and L929 cells after exposure to treated media for the time points of 45
minutes, 8 hours and 24 hours. Cells were analyzed using Five Photon’s membrane
potential assay. The graphs show change in fluorescence over time. When a cell is
depolarized the fluorescence increases and when it is hyperpolarized the fluorescence
decreases. Table 2 shows percent change between control and treated cells at the specific
time points below.
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Table 2.

Percent Change in Membrane Potential.

Cell Line

MDA-MB231
MCF-10A
B16
L929

45 Minutes in
Treated Media
as Compared to
Controls
↑70%
↑94%
↑60%
↑76%

8 Hours in
Treated Media
as Compared to
Controls
↑61%
↑31%
↑29%
↑35%

24 Hours in
Treated Media
as Compared to
Controls
↑32%
↑12%
↑34%
↑06%

Figure 9.
MDA-MB231 Cells Control versus Treated for 14 days.
Control (left) Treated (right).
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conduct an Annexin V-FITC Apoptosis Detection assay utilizing cell flow cytometry.
Upon completion of the cell flow analysis, we were unable to differentiate treated stained
and unstained in order to quantify the effect of interest. We then proceeded to phase and
fluorescent microscopy of the stained treated and unstained treated cells and we found the
treated cells displayed an auto-fluorescence in all color spectrums. Auto-fluorescence
interferes with detection of specific signals and is a natural emission of light by biological
structures such as mitochondria and lysosomes when they have absorbed light. The
treatment appears to induce auto-fluorescence and therefore the cell flow cannot
differentiate between the different groups. We did note there was a visible staining of
areas of the membrane in the treated group of the breast carcinoma in the FITC channel
representing annexin V staining when examined with fluorescent microscopy while there
was none noted in the control group (Figure 10). Figure 11 shows the different
microscopic appearance in the phase contrast pictures of the control and treated stained
cells.
Another interesting observed phenomena occurred when these cells in Figure 9
were placed back in standard DMEM, it appears that the cells that were rounding up and
appearing to undergo a cell death have continued to become apoptotic and form
disorganized cell clusters while the cells that were growing have continued to grow and
divide, albeit in with a different morphological appearance and at a slower rate since this
cell line characteristically becomes confluent in less than 5 days (Figure 12). We also
conducted an experiment where we grew MDA-MB231 cells in control and treated media
for 7 days and then placed both groups back in control media. On analysis of four
different groups: control days 1-7, control days 8-14, treated days 1-7 and treated days 814, we found that there was no change in the growth of the control group but there was a
decreased growth rate in both the treated groups when compared to control (Figure 13).
There was also a decreased growth curve noted in the treated cells when placed back in
the control media on day 8 when compared to the treated cells on days 1-7 and the
control cells on days 1-7. This suggests there may be a lasting change in the growth rate
of the treated cells once they are returned to control media after 7 days of growth in the
treated media. Further studies are warranted to quantify the mechanisms to explain this
observed phenomena.
We conducted an experiment where the MDA-MB231 cells were grown in treated
and control media for 8 days. At the end of the 8th day, the treated cells were placed back
in control media to see if the growth rate would correspond to the original growth rate
that occurred in days 1-8. The 95% confidence intervals were used to analyze the groups
and there was a significant difference in growth rates between the control and treated
cells when the cells had been growing in treated media for 8 days. The treated cells also
appear to continue to grow more slowly than the control with no rebound once they are
placed back in control media at day 8 (Figure 13).
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Figure 10.
MDA-MB231 Fluorescent Microscopy with Annexin Staining.
Control (left) Treated (right).

Figure 11.
MDA-MB231 Cells Phase Contrast Microscopy.
Control (left) Treated (right).
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Figure 12.
MDA-MB231 Cells Treated 14 Days versus Treated 14 Days and
Placed in Standard DMEM for 14 Days.
Treated 14 days (left) Treated 14 days and placed back in standard media (right).
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Figure 13.
MDA-MB231 Control and Treated Cells Grown in Control and
Treated Media for 7 Days and then Both Groups Placed in Control Media on Day 8.
Data were analyzed with GLM of SAS 9.4. The data were divided into 4 groups
analyzing cell growth/time. The slopes and 95 CI % within the treatment period were
analyzed. These 4 groups were analyzed: B11- control cell growth from day 1-8 (blue);
B12-control cell growth from day 8-12 (blue); B21-treated cell growth from day1-8
(yellow); B22-treated cell growth back in control media from day 8-14 (yellow). After
analyzing 95 CI %, we found that B11=B12 and these two slopes showed continuous
growth. We also found that B22 < B21 which suggests that there was no rebound in
growth of the treated cells when placed back in control media on day 8 and in fact there
was a reduced growth which suggests a reduced growth rate in these cells after grown in
treated media. When we compared B22 to B11, there was no overlapping of confidence
intervals between the two groups suggesting there was a significantly reduced rate of
growth in B22 when compared to B11.
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Differential Effects on the Recovered RNA and Protein Levels of Cancerous Cells
When conducting our microarray analysis on the MDA-MB231 cells grown in the
treated media for 3 days, we noted there was a significant increase in RNA in the treated
groups when compared to control (Figure 14). We then conducted an assay to determine
if this increase in RNA corresponded to an increase in protein production as well in the
treated cells. Upon analysis of the BCA protein data, paired t-tests showed no significant
difference in the protein content between the treated and control groups of MDA-MB231
cells after being grown in the treated media for 3 days (p = 0.71126). The control group
did show a slight increase in protein content over the treated groups although not declared
significant (Figure 15).
Differential Effects on mRNA Expression per Affymetrix 2.0 Microarray
Due to the significant effects that were seen in cell growth/proliferation, cell
cycle, membrane potential, and tubulin assay; Affymetrix 2.0 microarray analyses were
conducted on both the human breast carcinoma cell line and the human breast epithelial
cell in order to see what, if any, effects on gene expression could be measured. Data were
normalized using the RMA Sketch Global normalization function in an Affymetrix
expression console and analyzed with QIAGEN’S Ingenuity Pathway Analysis (IPA) to
identify relationships, mechanisms, functions and pathways of relevance in the data.
Results of this analysis indicated that the treated group of the carcinoma cell line
displayed a significant upregulation in pathways of the Unfolded Protein Response
(UPR), Phenylethylamine Degradation 1, tRNA charging and Serine and Glycine
Biosynthesis. Strong changes were also displayed in the upstream regulators of TRIB3,
PPRC1, ATF4, SCD and GNE. The expression of over 1,000 genes showed a 2- 18 fold
change after growth in the treated media compared to cells grown in the control media.
The significant changes in gene expression that were upregulated in the treated group of
the cancerous cells were in the areas of cell survival/death, cell cycle progression,
immune modulation and membrane potential. Endoplasmic r eticulum (ER) stress leads
to a compensatory mechanism in cells referred to as the Unfolded Protein Response
(UPR). The UPR is a cellular stress response that is related to ER stress and has been
known to be conserved in all mammalian species (Figure 16).46 The UPR shows
significant upregulation in these three arms that are used when the UPR is initiated in
order to restore function in the cell: 1) halting protein translation (see PERK-ERN1) 2)
degradation of the misfolded proteins (see EDEM2/ERO1-LB) 3) activation of signaling
pathways that lead to soliciting the help of molecular chaperones that are involved in
protein folding (IRE1, XBP1).46 The UPR also shows an upregulation in the apoptosis or
programmed cell death (CHOP/DDIT3/CHAC1) arm. Therefore, the microarray analysis
diagram below (Figure 16) shows significant upregulation (purple highlights) in all three
arms of the UPR and in the stress response leading to apoptosis of the MDA-MB231
cells. Finally, GADD34 (see below) is a CG3825 gene product from transcript CG3825RA that binds to PP1 and facilitates translational elongation of specific transcriptional
factors that lead to phosphorylation of eIF2-a, thereby terminating global protein
translation and inducing apoptosis.54 There was also a down regulation in many cell cycle

28

Figure 14.

RNA Recovered from Treated versus Control MDA-MB231 Cells.

Figure 15.
BCA Protein Analysis.
BCA protein analysis showing difference in the protein concentration at 0.2 mg/ml
dilution of MDA-MB231 cells when grown in control and treated media for three days Unpaired t-tests - Control mean 0.248; Treated mean 0.231; ts- 0.380879; df- 10; p =
0.71126. This shows no signficant difference in protein conentrations but does suggest a
slight decrease in the treated protein concentration when compared to control.
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Figure 16.
ER Stress/Unfolded Protein Response.
Data were analyzed through the use of QIAGEN’s Ingenuity® Pathway Analysis (IPA®,
QIAGEN Redwood City, www.qiagen.com/ingenuity).
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progression genes with an upregulation in many genes in the p53 pathway. Significant
changes also occurred with an upregulation in the tumor necrosis factors (TNF) as well in
the immune responses of several cytokines.
The MCF-10A cell line microarray showed an up regulation in the pathways of:
Superpathway of Serine and Glycine Biosynthesis I, Serine Biosynthesis, Role of IL-7A
and Granulocyte Adhesions and Diapedesis. While the microarray did show a significant
fold increased in the ER Stress and Unfolded Protein Response pathways in the MDAMB231 cells, it did not show an increased fold change ER Stress or the Unfolded Protein
Response in the MCF-10A cells. There was an 8-fold decrease in the CHAC1 expression
and this had been shown to correspond to a reversal in ER stress/UPR.106 The MCF10A
cells did not show a down regulation of cell cycle progression. There was a greater
increase in immune cytokines in the MCF-10A cells when compared to the MDA-MB231
cells. While the MDA-MB231 cells showed a significant fold change in the upregulation
of the p53 pathway, there was no up regulation in the tumor necrosis factors or the p53
pathway in the MCF-10A cells. Two heat maps were generated to show both the
microarray data and the real time PCR validations (Figures 17 and 18). A list of the gene
expressions for both the treated and control groups in both cell lines that were evaluated
and validated in order to make biological correlations to our experimental data are listed
in Table 3.
Validation of Differential Gene Expression by RT-qPCR of Cancerous and
Noncancerous Cells
Once all primers were tested for appropriate efficiency of 1.8-2.1 (Figure 19)
based on conformity of the standard deviations of all of the dilutions, cDNA was made
from 5 biological control samples of the MDA-MB231 cells and 5 biological treated
samples of the MCF-10A cells using the Transcriptor First Strand cDNA Synthesis Kit.
The RNA and all the above listed reagents were then placed in a thermal block
LightCycler 480 instrument with a heated lid and run through the 60 minute cycled
experimental program for denaturation, amplification, melting and cooling. The cDNA
was placed in a -80C freezer until use for real-time qPCR.
Real-time qPCR for each gene was run in triplicate for each of the 5 control and 5
treated biological samples. Relative quantification was used to analyze the changes in the
gene expression in the samples relative to the reference sample that was analyzed from
each of the biological replicates. Amplification curves were noted on all the gene samples
(Figure 20) and each sample was run in triplicate (Figure 21).
The ER Stress/UPR pathway genes of: ERN1, HERPUD1, XBP1, DDIT3 and
CHAC1 all showed a significant increase in gene expression in the treated MDA-MB231
cells. The ER Stress/UPR showed no up regulation in the MCF-10A by validation of
DDIT3. The CHAC1 gene in treated MDA-MB231 cells showed a 256-fold increase
which shows a strong response in the apoptotic arm of the UPR after 3 days in the treated
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Figure 17.
Heat Map from Affymetrix 2.0 Gene Expression Values.
(See Table 3) Values related to ER stress/UPR, immune/TNF, cell cycle, tumor targets,
cell death and membrane potential across the four conditions of the control and treated of
the MDA-MB231 and MCF-10A cell lines.

Figure 18.
Heat Map of Genes Validated with RT-qPCR.
TP53INP1, JMY, CASP4, ERN1, TNFRSF9, CHAC1, CLIC4, DDIT3, HERPUDI,
EROL1B, EDEM2, XBP1, ATF4, CCNE2 and HMMR.
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Table 3.
Normalized Affymetrix 2.0 Gene Expression Levels of MDA-MB231
and MCF-10A Cells for ER Stress/UPR, Immune/TNF, Cell Cycle, Tumor Targets,
Cell Death and Membrane Potential.
Gene
DDIT3
FBXW10
ERN1
CHAC1
CBLB
HERPUD1
FAM129A
ATF4
XBP1
TBC1D3H
SEL1L
EDEM2
EROL1B
PP1R15A
GADD45A
TP53INP1
DRAM1
PRSC1
GTSE1
JMY
IL1A
SPHK1
IL8
IL20Rb
TNFS4
TNFRSF10
IL21R
TRIB3
IL13RA2
OSMR
ABBC3
TNFRSF9
IFi30
CCNE2
HIST1H2BB
HIST1H2BM
HIST1H2AB
HIST1H3H
HIST1H2AJ

MDA-MB231
Control
Expression
92.20325
17.46405
167.6198
208.6184
300.1236
1783.141
885.9388
1885.499
1657.966
302.5868
1245.15
346.4626
198.7048
621.7018
206.6781
92.76067
678.105
573.9486
1697.772
240.5889
50.914898
224.5578
135.5218
216.931
38.17249
1322.594
88.24291
578.2565
268.6343
1435.055
265.6539
130.5561
3007.301
1550.488
1454.32
9383.078
206.6644
182.1673
49.123

MDA-MB231
Treated
Expression
604.7977
81.63718
1715.344
3336.654
1641.758
5490.769
2438.941
3100.368
3991.217
707.418
2877.084
758.4768
356.374
2642.331
855.5336
267.6483
1709.15
159.1545
476.1245
1179.91
682.6169
542.8292
542.5673
855.3889
104.0848
2931.227
186.0786
2925.584
714.5335
3519.421
648.5226
1854.911
826.8794
156.7187
176.3751
904.6331
31.26837
33.49529
11.901

33

MCF-10A
Control
Expression
74.5718
12.86469
180.1033
224.6349
293.6763
1948.906
164.713
884.2608
646.7754
295.0598
1030.507
246.9249
166.5647
445.151
669.77
458.6459
301.5608
89.98862
149.0838
483.9303
3773.235
74.35
285.7594
2492.348
31.551
679.15
34.35
534.79
10.6687
1430.7
1368.9
45.3355
1181.883
45.6
43.2
1089.2
16.4
47.7
8.85

MCF-10A
Treated
Expression
38.54762
19.93201
177.2253
67.11283
254.1021
1336.873
43.46248
612.7664
396.2133
210.7293
742.8039
121.0007
130.24
518.1046
766.9318
322.1881
301.5608
65.02022
150.521
433.1115
6656.809
84.3
689.56
2037.954
29.38311
354.5
34.02
197.3
15.999
1591.7
1353.1
33.309
1707.668
31.78
68.3
673.5
15.1
106.8
9.54

Table 3.
Gene
HIST1H4B
HIST1H2AM
HIST1H3B
HIST1H4A
HIST1H2BL
CASC5
HIST2H3D
HIST2H2AB
CDCA7
CDCA3
MCM10
E2F8
CENP1
DSCC1
CCNA2
CDKN2C
LMNB1
CHAF1B
PCNA
CENPE
SPC25
CLSPN
MYBL2
MAD2L1
CDCA2
CDC45
DLGAP5
SKP2
GRPR
KIF23
KIF15
CDK1
CDKN3
ORC1
KIF20B
CCNB1
PLK1
CDC20
TTK
SGOL1
CENPK

Continued.
MDA-MB231
Control
Expression
450.5416
167.8033
204.3861
219.4193
180.3614
2899.345
139.2912
4406.727
114.252
690.5287
2026.938
1701.76
1211.37
1055.73
3625.114
529.6627
105.6866
1302.628
3565.479
1585.373
973.4363
257.1571
663.0643
2916.937
1287.288
2032.203
3326.605
4475.243
462.8514
3014.659
1047.023
1191.199
2829.865
787.6633
1491.5
1460.134
7734.812
4119.106
2063.557
2204.15
965.4617

MDA-MB231
Treated
Expression
113.0835
42.64463
58.02624
62.61253
54.36535
956.1502
45.06532
1618.736
158.884
128.4345
409.4398
344.8467
248.7287
227.4702
813.5735
118.9669
23.76363
306.5765
859.501
386.5323
237.5617
63.77828
175.7511
761.4398
343.2617
546.5767
918.2717
1275.213
132.1584
1006.878
351.514
418.2505
818.9569
228.1306
485.3235
437.5147
2320.248
1241.424
623.2984
680.1693
298.0388
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MCF-10A
Control
Expression
22.25
22.93
11.73
21.9
164.2
485.2
79.91
1337.66
135.68
85.279
146.7
93.04
206.29
136.52
789.6391
86.3
170.453
266.99
708.95
384.29
68.93
45.25
162.5156
261.8003
277.99
194.04
294.9
1584.21
23.264
458.2247
210.2767
302.653
558.78
138.7296
479.7726
394.2499
2193.42
1542.313
404.7908
357.85
117.869

MCF-10A
Treated
Expression
18.6
16.9
6.98
15.2
93.9
499.3
59.5
491.5
139
66.4689
95.14
67.344
126.7361
53.78
715.2556
77.336
117.7738
156.226
627.721
280.6339
54.43
46.39
195.258
146.9315
314.51
135.39
322.08
1247.42
19.78769
432.4457
146.1035
219.0567
441.95
108.0838
370.89
414.196
1800.224
1298.382
388.5892
353.49
86.63

Table 3.
Gene
CDK15
OIP5
PRC1
AURKA
DNA2
PLK4
MCMY
FOXM1
CENPO
CDC25A
KIF4A
BORA
PRIM1
KIF23
BUB1
NUF2
CENPA
NEK2
CDC25C
CDK15
CIT
CCNF
CDCA8
ASF1B
CENPL
CCNA1
CENPM
KIF11
CDC45
CENPF
CASP4
CASP6
UNC5B
CARS
BEX2
JUNB
HMMR
PTTG1
FANCA
TGFB2
FAM83D

Continued.
MDA-MB231
Control
Expression
597.6559
656.4835
3544.327
1372.692
680.8584
740.555
1946.111
2150.082
1545.834
906.8274
1226.718
833.334
1933.796
3014.659
3482.412
1068.651
1604.808
1471.66
559.6721
597.6559
708.1124
509.6929
2367.439
3257.62
407.7961
1235.768
559.2139
3238.945
2032.203
1518.461
78.27916
315.9396
165.5258
410.5192
54.2207
700.5781
681.7925
267.0026
907.874
2404.895
2544.584

MDA-MB231
Treated
Expression
187.5154
210.1888
1135.643
441.3315
220.6961
241.9631
754.5332
834.0797
528.9465
355.5253
483.1996
333.975
639.5529
1006.878
1171.759
362.4769
623.0319
508.0363
194.3788
187.5154
251.2761
181.4399
856.6898
1238.113
156.0273
475.7696
212.9774
939.4666
546.5767
633.5304
167.4708
153.2165
1028.606
1051.12
128.0799
1589.828
183.141
72.87782
292.4976
897.6522
698.6316
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MCF-10A
Control
Expression
25.435
108.08
626.4265
241.9177
158.5015
118.182
316.8071
453.6553
173.4009
81.97407
285.4267
177.7702
289.6865
458.2247
535.3447
158.0058
259.9626
798.9699
150.2855
25.436
290.004
143.653
532.59
417.605
124.78
132.0476
116.38
708.69
194.04
1067.66
99.7621
110.2821
765.4645
212.4383
39.484
1304.435
504.2788
45.128
196.06
212.696
700.476

MCF-10A
Treated
Expression
22.931
65.89
457.0201
182.5047
128.2752
81.45791
318.7342
534.8372
134.9089
73.47563
325.8651
161.6121
144.092
432.4457
538.2644
117.314
173.262
809.4927
97.89624
22.93094
225.4576
115.1559
448.22
193.1282
103.6942
199.9614
91.68
495.69
135.38
1123.12
93.61928
103.9024
432.6196
107.2973
39.164
1068.991
362.3813
40.01671
128.35
258.4106
661.334

Table 3.
Gene
KIFC1
E2F1
CLIC4
CLIC2

Continued.
MDA-MB231
Control
Expression
1314.23
2050.937
2043.479
57.95258

MDA-MB231
Treated
Expression
428.6075
671.5983
5258.273
117.7829
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MCF-10A
Control
Expression
179.392
108.8849
2021.464
345.69

MCF-10A
Treated
Expression
145.62
92.29729
1791.211
274.86

Figure 19.
Primer Testing for TNFRSF9.
All primers were designed and then tested on cDNA from MDA-MB231 cells. This
shows the amplification curves of the 5 different dilutions used for TNFRSF9. The
expression values for each dilution are plotted on a standard curve. An efficiency is
determined based on the slope and y intercept. An efficiency of 1.8-2.1 is required for
each primer prior to validation experiments. Each of the primers were designed for each
gene and taken through efficiency testing prior to real time qPCR validation on the genes
of interest.
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Figure 20.
Amplification Curves of Fluorescence over Cycles for Real Time
qPCR with Triplicate Testing of Gene Expression on a 96 Well Plate when
Comparing Control and Treated Gene Expression Levels of MDA-MB231 Cells.
The fluorescence occurs using TaqMan probes that become degraded by Taq polymerase
and releases the fluorophore thereby relieving the quenching effect. The fluorescence
detected in the quantitative PCR thermal cycler is directly proportional to the fluorophore
released and the amount of DNA template present in the qPCR.

Figure 21.
Amplification Curve - RiboS19.
Amplification curves in triplicate of housekeeping gene used for extrapolation of control
and treated data for real time qPCR.
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media, but was significantly down regulated in the MCF-10A cells.39 The TNFRSF9 gene
showed a 128-fold increase in a player in the TNF/TRAIL pathway. TNFRSF9 has been
shown to be expressed in activated T cells (CD8 & CD4), dendritic cells, natural killer
cells, granulocytes and blood vessel inflammation.100It has also been shown to stop
tumors in mice.107 The Junction Mediating Protein (JMY) is a p53 cofactor that codes a
tumor suppressor protein and is up regulated 4-fold in our validations. It is believed to be
a key transcriptional regulator and controls DNA repair, cell cycle progression,
angiogenesis and apoptosis.101The loss of p53 function is thought to be a contributing
factor in the majority of cancer cases. Caspase 4 (CASP4) is the caspase that is linked to
ER Stress/UPR and it is up regulated 8-fold.102 Cyclin E2 (CCNE2) is down regulated
32-fold and has been shown to be elevated in tumor-derived cells and plays a role in the
G1/S transition in the cell cycle.103 Hyaluronan-mediated motility receptor (HMMR)
interacts with BRCA1and other proteins to control key aspects of cell polarity and cell
division and may hold answers to how to treat women with BRCA1 and BRCA2
mutations as its expression and overexpression has been linked to ras transformation,
tumor progression and metastasis.104 HMMR is down regulated 16-fold on our
validations. Chloride Intracellular Channel 4 (CLIC4) is a group of proteins who regulate
cell membrane potential, transepithelial support, maintain pH and cell volume. Under
expression or reduced CLIC4 alters the redox state of tumor cells and enhances tumor
development.105 It is upregulated 8-fold in our gene validations (Figure 22). Unpaired ttests were conducted on MDA-MB231 and MCF-10A gene validations (Table 4).
DISCUSSION
The initial cell growth studies found significant growth inhibition of the B16
murine melanoma and the MDA-MB231 human breast carcinoma while failing to show a
growth inhibitory effect on the L929 mice fibroblasts and the MCF-10A breast epithelial
cells. We conducted various experiments to see how long and under what conditions
these effects were noted. The treated water alone appears to retain the ability to reduce
cell proliferation of cancerous cells for up to 21 days. Once the treated water is combined
with the components to make the growth media, the treated hypotonic saline solution
appears to lose its effects on day 5 or 6 since cancerous cells were observed to show a
significant increase in cell growth/proliferation at this time point. A possible explanation
for this can be hypothesized and is discussed extensively in chapter 4. The treated water
appears to retain the effect created by treatment with the CETS system for a longer time
period (21 days), as shown by growth inhibitory effects of cancerous cells when grown in
media made with stored treated water, than does the treated growth media once it is made
with the treated water as shown by the effect waning on day 5-6. This addition of other
molecules/ions to the media could in effect, nullify or change the effects induced by the
CETS system once added due to molecular changing/bonding that occurs between the
various ions contained in the water and ions added with the growth media contents.
The cancerous cells also began to show a microscopic change of ‘rounding up’
after they were growing in the treated media for several days. The growth inhibitory
effects and the ‘rounding up’ led us to cell cycle analyses, where we noted the cell cycle
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Figure 22.

RT-qPCR Fold Change.

Table 4.

Unpaired t-Tests of RT-qPCR.

Gene
MDA-MB231
CHAC1
HERPUD1
EDEM2
XBP1
TNFRSF9
JMY
CCNE2
HMMR
DDIT3
CASP4
CLIC4
MCF-10A
DDIT3
CHAC1

df

Unpaired t-Tests
ts
p

8
8
8
8
8
8
8
8
8
8
8

26.796
7.72534
1.1876
12.7308
26.7993
25.3296
7.79364
6.38892
8.75038
7.6846
11.0548

.000000004
.0000561
.269047
.00000136
.0000000004
.000000000682
.000108
.000212
.0000228
.0000583
.000004

13.26134
7.53
9.3
5.74
13.55
9.7
6.24
6.744648
11.23
8.214653
5.17264

6.184
5.1
9.8
4.34
8.05
7.4
10.74
10.32
9.53
5.63
3.106

8
8

0.05804
12.0055

.955142
.00000214

12.668
13.00

12.678
16.7
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Mean/Control Mean/Treated

arrest in the cancerous cells while the noncancerous cell lines, showed no change in the
cell cycle in either the treated or control groups. We then proceeded to conduct the
Annexin V-FITC Apoptosis assay on the cancerous cell lines where we were unable to
quantify any differences between the stained and unstained treated groups due to an
autofluorescence that was induced in all the treated cells when analyzing by flow
cytometry. We then conducted fluorescence microscopy on the treated and control
cancerous cells and could visualize the green fluorescence associated with annexin
staining. This observation suggests the binding of the Annexin staining to
phosphatidylserine and the early stages of apoptosis in the cancerous cells that had been
grown for 3 days in treated media. The green fluorescence was not seen on fluorescent
microscopy with the control cancerous cells which suggests the control cancerous cells
were not undergoing apoptosis.
Due to the Vmem differences in cancerous and noncancerous cells, we decided to
conduct membrane potential assays to determine if the treated media was causing a
change in the membrane potential of the cells. The membrane potential findings suggest
that the cells are initially hyperpolarized by exposure to the treated media and then begin
to depolarize within the first 8 hours. By 24 hours the noncancerous cells have returned to
their original baselines but the cancerous cells stay at a more polarized level than their
original baseline. The CLIC4 gene is known to participate in membrane potential
regulation and is a known tumor suppressor.105 CLIC4 is upregulated 4-fold in the treated
MDA-MB231 cells in the RT-qPCR validation but was not upregulated in the
noncancerous cells. This genomic change in expression in a gene in the cancerous cells
that controls membrane potential regulation corresponds to the membrane potential assay
testing. This suggests the treated media shows an effect in the regulation of membrane
potential in cancerous cells who are known to possess a depolarized membrane when
compared to a noncancerous cell.
The microarray and RT-qPCR validations on the MDA-MB231 cells showed the
unfolded protein response (UPR) as the top pathway affected significantly by the CETS
unit and this pathway was not upregulated in the microarray and the RT-qPCR of the
MCF-10A cells. The UPR is a series of signaling events that occur due to intracellular
stress from misfolded proteins in the lumen of the endoplasmic reticulum (ER). Certain
pathologic stimuli can cause an interruption in the protein folding process and these
include but are not limited to: calcium depletion, altered glycosylation, nutrient
deprivation, oxidative stress, DNA damage or energy fluctuations.38 While no significant
increase in protein synthesis was found with the BCA protein assay of human breast
carcinoma, data showed a 2.5 fold increase in mRNA between the treated and control
groups. The increase in mRNA indicates a possible increase in transcriptional affects
may be initially occurring prior to the up regulation of ER stress/UPR pathways. The cell
size appears to increase initially in our cell size data and the cells then begin to shrink
which could suggest the halting of protein synthesis and the ER degradation/protein
degradation that occurs with the UPR survival response. UPR has been shown to be
activated by increased activation of ATF4 and increased transcription of its target C/EBP
homologous protein (CHOP), which is a pro-apoptotic factor.37 ATF4 is a strong
upstream regulator in our microarray analysis. The known causes of UPR are energy
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fluctuations. This suggests a possible connection between the significant changes in the
membrane potential of the cancerous cell lines and the upregulation of the UPR. The
treated media did not illicit a growth inhibition in the noncancerous cells, which shows
that growth arrest from UPR is likely not occurring in the noncancerous cells and also
lends to the thought that other known causes of ER stress related to nutrient or calcium
deprivation from the media are most probably not originating factors in the cancerous cell
lines. The RT-qPCR validated that ER Stress/UPR gene expression was not up regulated
and this corresponds to the experimental findings with the MCF-10A cells. The cell
growth studies found cancerous cell lines significantly slowed mitosis and halted their
cell cycles. In ER stress there is a struggle to balance adaptation and alarm/death. UPR is
often highly activated in cancer cell to promote survival. In the RT-qPCR validations,
ERN1 is upregulated 14-fold, which could suggest one mechanism for cell cycle arrest
and DDIT3 (CHOP) is upregulated 4-fold, while CHAC1, which is downstream from
CHOP is strongly upregulated 256-fold and could indicate that these cancer cells are
headed down the apoptosis arm of the UPR after 3 days of exposure to the treated
media.51 CHAC1 is the pro-apoptotic component of the unfolded protein response
pathway that mediates the pro-apoptotic effects of the ATF4-ATF3-DDIT3-CHOP
cascade.39 Caspase 4 was significantly upregulated 4-fold as well in the RT-qPCR and
this is the caspase that is linked to the UPR and could suggest a possible beginning to a
cell death.49 An unsuccessful UPR can also be caused by an increase in TNF, which was
also significantly upregulated 126-fold in the RT-qPCR and operates down the IRE1TRAF2-JNK pathway in ER stress.47 TRIB3 was shown to be a significant upstream
regulator in our microarray, which is a known sensitizer of cells to TNF and TRAIL
induced apoptosis.55
In our microarray, TP53INP1 is significantly upregulated gene that is involved in
making a protein that has anti-proliferative and pro-apoptotic properties and acts as a
regulator of transcription and autophagy. This gene plays a major role in the p53/TP53
oxidative stress response and was also validated with RT-qPCR as a 4-fold increase with
JMY. It is possible that ER stress/degradation and anything that leads to the UPR could
nonspecifically halt DNA replication leading to p53 activation and apoptosis.41,43
TP53INP1 can also reduce cell migration by regulating the expression of SPARC.44
The microarray found that TNFRSF9 was also found to be significantly
upregulated downstream from the also significantly affected ER transmembrane protein:
Inositol Requiring 1 (IRE1). Prolonged ER stress has been shown to activate the proapoptotic IRE1-TRAF2-JNK pathway. Tumor necrosis factor receptor superfamily,
member 9 is a member of the TNF receptor superfamily that is implicated in the survival
and development of T cells. It is a significant player in the 4-1BB Signaling in T
lymphocytes pathway, which is known for eradication of established tumors, enhancing
integrin-mediated cell adhesion and increasing T cell cytolytic potential. TNFRSF9 is
also linked to the Death Receptor Signaling and NF-KB pathways.42 Even though tumor
necrosis factors are not playing a role in these in vitro experiments, they could be a strong
player in a future in vivo model. Also, CLIC4 codes for a diverse group of proteins that
regulates cellular processes, such as stabilization of cell membrane potential. CLIC4 has
been shown to participate in suppression of tumor growth and the absence of decreased
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levels of CLIC4 has been found to contribute to TGF-B resistance and enhances tumor
development.45 Membrane potential assay results correlate with this finding. These
significant changes of CHOP, CHAC1, JMY/P53, and CASP4 in the microarray/RTPCR, Annexin V fluorescent microscopy and the noted microscopic effects of nuclear
fragmentation, blebbing and decrease in cell size suggest a possible apoptosis or other
form of undetermined cell death may be occurring in these treated human breast
carcinoma. Interestingly, the MCF-10A cell line did not show these experimental or
genomic effects and show this could be a possible side-effect free adjunct therapy for
cancer patients. More funding and research is needed to verify what is occurring in these
cells.
CONCLUSION
Understanding how energy fluctuations can contribute to UPR and other genomic
signaling offers a new opportunity to exploit the programmed balance of survival and cell
death in order to catapult the cancerous cells past levels compatible with survival.
Combining chemotherapeutic and pharmacologic treatments with this potentially known
ER stressor from hyperpolarization in cancerous cells can potentially augment cell death
and increase chemotherapeutic efficacy. Chemotherapeutic agents that cause ER stress
such as brefeldin A, Velcade and geldanamycin, could be effective in enhancing UPR in
order to promote apoptosis in cancer cells.40 To obtain ER homeostasis, eukaryotic cells
have developed or evolved the UPR in order to have an adaptive intracellular signaling
pathway that is essential when a response to metabolic stress, oxidative stress,
inflammation, neurodegenerative disease or cancer is needed. UPR is a survival
mechanism that is often used by cancerous cells. Could the hyperpolarization of the cell
membrane in these cancer cells lead to an ER stress induced UPR that becomes too
challenging for these cancer cells to overcome leading to a transition from the
adaptive/protective stage to the pro-apoptotic/pro-death stage? The microarray and RTPCR validations show the cancer cells heading down several pro-apoptotic pathways
related to ER stress/degradation, as well as the p53 oncogene activation pathway while
these validations also show this effect is not occurring in the noncancerous cells. The
mechanism of triggering p53 signaling during ER stress induced apoptosis is currently
unknown but may possibly be associated with a hyperpolarized membrane according to
both our experimental findings and the genomic analyses. Two of the top pathways
delineated in our microarray according to our Ingenuity analysis were also shown to be
serine biosynthesis and the super pathways of serine and glycine biosynthesis. The tumor
suppressor p53 has been classically known to regulate DNA repair, cell-cycle arrest and
apoptosis. In the process, these actions will upregulate metabolic targets and thereby
upregulate these pathways of biosynthesis.52 The upregulation of serine and glycine
biosynthesis is an essential reversal of how cancer cells can usually reprogram their
metabolism by shifting from oxidative phosphorylation to aerobic glycolysis (Warburg
effect) in order to achieve unchecked growth.53 The amplification of metabolic enzymes
has been found in breast, liver, prostate and melanoma cancers due to the identified
amplification of the gene encoding phosphoglycerate dehydrogenase (PHGDH) leading
to increase flux through the serine/glycine pathway.60 PHGDH increase has been linked
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to increased proliferation of cancerous cell lines.60 Our data suggest an increase in
PHGDH and the serine/glycine super-pathways can also be possibly linked to decreased
proliferation in cancerous cells lines under the right conditions, while conversely, this
pathway was also upregulated in our noncancerous cell line, which did not show a halt in
cell cycle or cell growth. In recent years, the study of metabolism has returned to the
forefront of cancer research. Data now support that altered metabolism can possibly
result from the reprogramming by altered oncogenes and tumor suppressors. Our data
suggest that restoring the altered oncogene and tumor suppressor functions could return
the cell to a normal metabolism. Altered metabolism as well as an altered immune
response should continue to be considered two major hallmarks of cancer that is studied
in future research.
Could hyperpolarization of the cell membrane hold the key to unlocking multiple
mechanisms that lead to cancerous cells cell cycle arrest, increasing and then the
abandoning of the UPR as a survival mechanism, becoming sensitized to TNF and
TRAIL activation, and activation of p53, thereby causing eventual apoptosis or another
type of cell death, while not illiciting the same response in a noncancerous cell? The
cancer cells appear to have increased anabolic function with the upregulation of the
serine/glycine super pathways (nucleotide formation), increased catabolic function with
the upregulation of phenylethylamine degradation pathway (carbon and nitrogen source)
and reprogramming of the UPR and p53 genomic apoptotic mechanisms. There are many
forms of cell death that include but are not limited to apoptosis, entosis, mitotic
catastrophe, necrosis, necroptosis, excitotoxicity, autophagic cell death, and pyrotosis.61
Dying cells are engaged in a process that is reversible until a “point of no return” is
passed.61 The MDA-MB231 cells appear to be headed down a cell death pathway, while
the MCF-10A cells do not. The cancerous cells that appear to survive the exposure to the
treated media also appear to display different characteristics of slower cell growth when
placed back in standard/non-treated media (Figure 13). This slower cell growth could
suggest some form of change in cell metabolism/function. Many other associated gene
expressions that are linked to control of tumorigenesis, tumor development, cell
migration and cell differentiation have been shown significant in our microarray and
warrant more research. The upregulation of IL1A (IL10) and TNF also have been linked
to an unsuccessful UPR and could also lead to research in the autoimmune response to
disease. There are also strong down regulatory changes that are linked to cell cycle check
points as well as cell cycle progression. Hyperpolarization of the plasma membrane could
in theory be a reprogramming of a cancer cell to behave like a normal cell that has lost its
ability to function as a beneficial member to the organism; whereas a cell cycle arrest and
eventual cell death cascade is initiated. Hyperpolarization of the noncancerous cell line
does not appear to similarly affect these same pathways. There appears to be a slight
down regulation of the ER Stress/UPR pathway, which could show promise for other
chronic diseases such as neuro-generative diseases, organ fibrosis and diabetes that have
also been linked to an aberrant UPR. There is a significant differential effect with regards
to ER Stress/UPR and many other metabolic functions of the cell with the CETS treated
water when one compares the cancerous cell versus noncancerous cell line responses.
More research is warranted to further verify and validate these observed effects.
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CHAPTER 3.

HYPERPOLARIZATION OF PLASMA MEMBRANE
ENHANCES WOUND HEALING
INTRODUCTION

Wound healing is a critical process that, if impaired, can increase the risk for
infections, complications, patient discomfort and slow the return to activities of daily
living. Many of the biological mechanisms that both drive and prevent chronic wound
healing are poorly understood.16,63 Cell migration plays a key role in both the spread of
cancer cells and in wound repair. Some acute wounds are known to heal quicker with
electric stimulation such as is used in orthopedics and sports medicine where an electrical
signal can lead to an upregulation of cartilage matrix protein production and nitric oxide
dependent chondrocyte proliferation from a bone growth stimulator.64,67 On the contrary,
chronic non-healing wounds that occur with diabetes, malnutrition, infection, chronic
inflammation and aging currently have no effective therapy available and treatment for
the biological impediments remain elusive.62 Thus, chronic wound care generates a very
challenging and significant economic burden to our health care system.68
One hundred and sixty years ago, Du-Bois Reymond, founder of
electrophysiology, identified electromagnetic fields on a hand wound.68 Electromagnetic
fields were recently shown to activate multiple signaling pathways that are instrumental
in wound healing. Unlike other wound treatments, electromagnetic fields have the
intrinsic property of being directional (polarized).9,14 Cell migration
(electrotaxis/galvanotaxis) appears to be driven by electromagnetic induced polarized
signaling of epidermal growth factor receptors, integrins, and phosphoinositide 3
kinase/Pten, and some research also points to involvement of protein kinase C,
intracellular calcium, and cyclic adenosine monophosphate.63 Electromagnetic fields
have also been found to override other signaling cues of cell migration such as:
chemoattractant gradients, injury stimulation, contact inhibition, wound void and
population pressure.65,66,2 When an electromagnetic field of physiological strength is
applied in the opposite direction of these signaling cues, cell migration begins to follow
the direction of the electromagnetic field.63 Plasma membrane potential (Vmem)
differences have been found in injured and proliferating cells.12,13 Injured and
proliferating cells have a measurable depolarized membrane potential of approximately <
-30mV, while healthy and non-proliferating cells have a resting potential of
approximately > -70mV.12,17 Cells have been shown to respond to different
electromagnetic signals when undergoing division, migration and differentiation.63 It has
been found that magnetic fields involve the changing gradients of Vmem that are
produced and sensed by non-excitable cells in living organisms.17,18 Therefore,
bioelectricity shows an effect well beyond excitable cells and has been shown to affect
wound healing, cell migration, nerve growth and limb regeneration.3,4,24
Previous basic and clinical electromagnetic therapy wound care research has
historically been conducted with a vibrating probe technique that places a flow of
positive charge directed toward the wound both in vitro and in vivo. This probe technique
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has shown great promise with affecting not only the motility of the cells but also the
directional migration of the cells in vitro.63 Impaired cell migration is characteristic of
chronic wounds and in order to heal, cells must migrate directionally and in an organized
fashion.65 Unfortunately, extrapolation and translation of the use of these applications
that are successful in vitro have major challenges to overcome in vivo.63 To date, the
exogenously applied electromagnetic probe stimulations in patients have generated
highly variable current density and voltage distributions that have led to high
discrepancies in the reported clinical trials. Currently, electromagnetic stimulation is
being utilized in some non-healing chronic wounds but there are no FDA-approved
devices for the indication of chronic skin wounds due to the lack of significant wellcontrolled randomized clinical trials and standardization of the devices used for electrical
stimulation. Currently, scientists remain baffled as to how cells actually sense
electromagnetic fields.8,9
We will discuss our experiments that have been conducted to show how the
treatment with a device called the Cellular Energy Transfer Science (CETS) system that
uses an electromagnetic field could open the door for future wound care applications. The
CETS system has been used across the globe for 20 years in holistic markets and
administered in the form of footbaths and baths with reports of pain relief, increased
stamina, improvements in renal and hepatic function, support in cancer treatment
recovery, decreased recovery time from illness and injury and many other health
applications.15 Users of this device have also reported faster or improved wound healing
after immersing part or all of their body in the water for 20–35 minutes every other day.
In chapter 2 I showed that the noncancerous cell lines did not exhibit a growth inhibition
when exposed to the CETS treated growth media and this along with the anecdotal
testimonials from across the globe led us to conduct cell migration experiments. We will
discuss the scratch assay, membrane potential assay and microarray analyses that when
coupled with anecdotal reports from across the globe, offer a strong argument for future
translation to chronic wound clinical trials. We hypothesized that there would be a
differential effect on cell migration between treated and control groups of murine
fibroblasts (L929 cells).
METHODS
Murine Fibroblasts (L929 cells), treated (5 x 105) (n = 18) and control (5 x 105)
L929 (n = 18) were cultured in 60 mm petri dishes in standard Dulbecco’s Modified
Eagles Medium (DMEM) with 10% fetal bovine serum (FBS) and allowed to grow to
90% confluence; then, a 3mM hypotonic saline solution that had been treated with the
CETS system was used to prepare treated media. DMEM 10X from Sigma Aldrich
Laboratories was diluted 9:1 with CETS treated water and glucose, sodium bicarbonate,
folic acid, glutamine and fetal bovine serum (10%) were added to achieve a high glucose
DMEM- 10 high glucose concentration (See Chapter 2). DMEM 10x was also diluted 9:1
with 9 parts of a 3mM hypotonic saline solution that had not been treated with the CETS
unit to 1 part DMEM 10X to achieve a DMEM-10 with high glucose concentration. The
standard DMEM–10 that the cells were initially cultured in was aspirated and replaced
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with control and treated media in the respective plates. Then, a “scratch” in the cell
monolayer was made with a p200 pipet tip that was attached to low suction. It is
important to create scratches of approximately similar size in the cells to minimize
possible variation by the difference in the width of the scratches. Three scratches in
parallel were made on each 60mm dish along with 2 reference points that consisted of
two perpendicular lines to the scratch lines made with a permanent marker on the bottom
of the dishes. These reference points are critical to ensure consistent orientation to the
same microscopic field when taking pictures and to insure accuracy of these
measurements. We made sure we kept the reference lines in the picture for a reference
point in each scratch to insure we were photographing the same cell growth point of each
photograph at each time interval.
Pictures were taken along each scratch/wound at the time of scratch and then at 3
hour intervals until confluence in the treated group was reached at12 hours with a 10x
eye piece and 40x objective utilizing AxioVision Imaging System. This time interval was
based on known doubling times of this cell line. The cells were placed in a 37o C/CO2
incubator between picture time points.
Quantification of cell migration rate can be reported by the percentage change in
area over time (Equation 1):
M (t) = A (t) – A (0) x 100
A (0)

Eq. 1

Where A (0) is the initial area enclosed by the population of cells, A (t) is the area
enclosed by the population of cells at time t, and M (t) is the percentage change in area at
time t. Estimates of cell migration rates using this equation are often obtained by hand
tracing that area enclosed by the leading edge of a spreading cell population and this can
be subjective. To overcome this limitation, we used an automated image analysis
software, ImageJ to outline the leading edge of the cell migration. ImageJ is a public
domain, Java-based image processing program developed at the National Institutes of
Health. It performs standard image processing functions such as logical and arithmetical
operations between images outlined by sharpening, smoothing, edge detection and
median filtering in order to develop geometric transformations and accurate measurement
of the area of the wound. This accurate measurement of the wound area can then be used
to calculate percent change in area of wound over time.
RESULTS
After analysis with ImageJ software to obtain the percent area of wound healed
over time, we conducted Student’s t-test between the percent change in area at the time
points of 3 and 9 hours. There was a significant difference in percent area of wound
healed over time in the treated versus the control groups (Figure 23). On observation of
the wound picture that was taken at the 9-hour time point in the treated wound (Figure
24), healing appears to be in an upward fashion from the bottom or an upward directional
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Figure 23.
L292 Cells Scratch Assay- Percent Area Healed/Time.
L929 cells Scratch Assay; mean (C)-152057; mean (T)-78198.22; df = 16; ts = 5.577858;
p = 0.0000416.

Figure 24.
L292 Treated Cells Scratch Assay.
Baseline (left) and 9 hours (right).
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migration. The control wound (Figure 25) appears to lack directional migration (9-hour
time point) and has few cells that have migrated into the wound as compared to the
treated wound at the same time point of 9 hours.
DISCUSSION
The CETS treated media appears to hyperpolarize the membrane of the murine
fibroblast when compared to the control group as discussed in Chapter 2 in our
membrane potential analyses. The treated media also shows increased wound healing
similar to what is described with the voltage pulsed currents of AC and DC that are
applied with the probes in vitro.64 The pulsed probed applications have not been effective
to date in clinical trials.64 The treated wound in Figure 24 shows the treated murine
fibroblast migrating more quickly, while Figure 25 shows the murine fibroblasts
migrating sparsely and randomly. We know that injured and proliferating cells have a
depolarized membrane when compared to non-proliferating cells.19 The CETS treated
L929 cells show a hyperpolarization or an increase in membrane potential in our assays
from baseline to 72 hours post treatment.
An Affymetrix microarray was conducted on human breast carcinoma (MDAMB231) and human breast epithelial cell (MCF-10A) that had also been grown in the
CETS treated media and a significant upregulation of genes related to wound healing and
cancer were found. Two major genes that are associated with multiple pathways are
vascular endothelial growth factor (VEGF) and Amphiregulin (AREG). VEGFA is a
member of the PDGF/VEGF growth factor family and encodes a protein that is a
glycosylated mitogen that acts on endothelial cells and affects angiogenesis,
vasculogenesis, as well as endothelial cell growth, through the promotion of cell
migration, cell growth and inhibition of apoptosis. It is associated with 9 different
significant pathways.63 AREG encodes a member of the epidermal growth factor family,
which is an autocrine growth factor as well as a mitogen for astrocytes, Schwann cells
and fibroblasts. AREG is related to epidermal growth factor EGF and transforming
growth factor (TGF-alpha).69 This protein associates with the EGF/TGF-alpha receptor to
promote the growth of normal epithelial cells while inhibiting the growth of certain
aggressive carcinoma cell lines.70 Since these genes are strongly implicated in the
literature as significant targets for wound care treatment and they have been found to be
significantly upregulated in our microarray analysis of treated versus control human
breast carcinoma cells and treated human epithelial cells, future plans include QRT-PCR
validation of these genes in these cell lines is warranted. If validations of the same genes
are found in these cell lines, hyperpolarization with the CETS system may offer an
electromagnetic application that could unlock the mystery of electromagnetic signaling of
cells in vivo that could offer a new wound care treatment.
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Figure 25.
L292 Control Cells Scratch Assay.
Baseline (left) and 9 Hours (right).
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CONCLUSION
Wound care presents significant challenges to our health care system. Some
success has been found in vitro with voltage pulsed currents of AC or DC as well as with
electrical stimulation of acute wounds in vivo. The CETS system has been shown to
hyperpolarize the cell membrane and data suggest improved wound healing through
faster cell migration. The microarray data in our MDA-MB231 and MCF-10A cells
suggest mechanisms occurring with CETS use may be similar to what has been observed
in vitro with previous wound care research.63,64 Anecdotal reports of improvements in
patients with chronic and acute wounds following the use of the CETS are also consistent
with these in vitro studies.15 Because muscle is also built by the breakdown and
rebuilding/repair of the muscle cells and fibers as is done by athletes in weight training
etc., it could be inferred that applications of the CETS might extend beyond acute/chronic
would care. For example, when a cell membrane can be safely hyperpolarized, the
damage/breakdown of the muscle fibers that occurs from an athlete with training and
performance in athletic events could be restored to health more quickly just as the
acute/chronic wounds appear to respond. This could lead to decreased recovery time as
well as enhanced performance of athletes as well as expand the application from repair of
wounds of chronicity to repair of high performance wounds. AREG has been shown to
participate in certain EGFR and STAT3 signaling, cell cycle progression and in
tumorigenicity in certain cancers.69,70 AREG has also been shown to be overexpressed in
wounds that are healing.69,70 Hyperpolarization could be differentially affecting the same
pathways that are used by both cancerous cells for invasion and proliferation and
noncancerous cells for migration and healing. Hyperpolarization of the cell membrane
could be affecting the poorly understood endogenous electrical cues of the cell that
ultimately lead to the guiding of the cell in ways that are most beneficial to the organism.
Further bench work and clinical trials are needed to verify the potential beneficial effects
of the CETS system on cell migration, wound healing and tissue repair.
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CHAPTER 4.

CELLULAR ENERGY TRANSFER SCIENCE SYSTEM
MODULATES MAGNETIC IONS IN WATER
INTRODUCTION

The Cellular Energy Transfer Science (CETS) system is a device that generates an
electromagnetic field in water. This device was developed in Australia in 1996 by Terry
Skrinjar as a water apparatus that was originally designed to affect plants, animals and
humans by increasing conductivity and water tension is such a way that it positively
affects ion exchange at the cellular level. This device was one of two devices that
conformed to the original device and this one which was tested was brought to the United
States for manufacturing and marketing in Robertsdale, Alabama in 2001. It has been
marketed in alternative health markets as the Aqua Chi and the Total Charge. This device
consists of a power pack and a module. The power pack converts alternating current (AC)
to direct current (DC) and delivers 2.5 amperes of DC to the module that is submerged in
water. The module is comprised of a set of spaced, electrically conductive stainless steel
rings that are arranged in parallel on a common axis and with two plates being charged,
one positively and one negatively and 4 opposing electrically conductive plates (Figure
26). The center ring/plate is composed of copper and is not part of the circuit since it does
not have current flowing through it due to the fact it is a non-magnetic metal. The module
is designed to affect any living organism that comes in contact with the water that has
been treated with the CETS system. This living organism can be in contact with the water
in a footbath/bath while the DC is actively running to the module to achieve a direct
“effect,” or can be placed in the water after the DC has run through the module in the
water for 30 minutes to achieve an indirect “effect.” People and animals have been taking
footbaths across the globe with this original design for 20 years to achieve a direct effect
and we have conducted in vitro experiments where an indirect effect has been
scientifically tested.
BACKGROUND
Magnetic Properties of Metal Ions
Every material is known to be influenced in some way by magnetic fields.74 The
water that was used in these laboratory experiments is de-ionized water that has been
made to a 3mM NaCl by the addition molecular grade 5M NaCl to supply ions in the
water so it can carry a measurable current. The rings in the CETS system consist of
stainless steel and a copper ring. The stainless steel rings contain chromium, nickel and
molybdenum. Materials can be classified by their response to externally applied magnetic
fields as diamagnetic, paramagnetic, ferromagnetic and/or anti-ferromagnetic and their
magnetic responses differ vastly in strength.75 The actual classification of a material’s
magnetic properties is based on its magnetic susceptibility (X) which is the ratio of the
induced magnetization (M) to the applied field (H).74 The magnetic moments of
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Figure 26.

CETS Module.
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ferromagnetic materials align parallel to H and this allows for the coupling interactions
between electrons of the material leading to very ordered magnetic states.74 The factors
involved in this process depend on temperature, external field (H) and the atomic
structures.74 Chloride and copper’s atomic structures lend them to the classification of
diamagnetic metals.71 Diamagnetism is a very weak magnetism that is nonpermanent and
persists only when an external magnetic field is being produced. These metals create an
induced magnetic field in a direction opposite to an externally applied magnetic field and
are actually repelled by the magnetic field.71 Molybdenum and sodium are paramagnetic
metals, which are attracted by an externally applied magnetic field and form a magnetic
field in the same direction of the magnetic field and the strength of this magnetism is in
proportion to the applied field. Both diamagnetic and paramagnetic metals are considered
to be nonmagnetic, because they only display magnetism when in the presence of an
external field.71,76 Nickel is a ferromagnetic metal, which continues to display a
permanent magnetism with or without a presence of a magnetic field. Magnets are an
example of ferromagnetism because they retain their magnetic properties. Ferromagnetic
effects are very large and are considered the strongest form of magnetism and often
produce magnetism of greater magnitude than an applied field.71,76 Chromium is one of
the few (2) known anti-ferromagnetic metals in our periodic table. In antiferromagnetic
materials, the magnetic dipole moments (behaves like tiny magnets) of atoms align in
opposing directions of the ordered magnetism of ferromagnetic atoms.76 This leads to
parallel spin of electrons (ferromagnetism), which creates a magnetic moment (polarity),
and antiparallel spin of electrons (anti-ferromagnetism) which creates an opposing
magnetic moment (opposing polarity).82,83 The combination of the ferromagnetism and
the anti-ferromagnetism greatly strengthens the magnetic field produced by the
spin/current of the electrons in the water.76
Magnetic Spin, Magnetoresistance and Lorenz Force
All atoms have inherent sources of varying strengths of magnetism because
electron spin produces a magnetic moment and the electron orbits act as current loops,
which produce a magnetic field.81 As stated above, the strength of a field is enhanced,
when there are both parallel and anti-parallel spinning in electrons from the combination
of ferromagnetic and anti-ferromagnetic metals that are exposed to that field.82 Giant
Magnetoresistance (GMR) is a quantum mechanical magnetoresistance effect observed in
thin-film objects that are composed of alternating ferromagnetic, anti-ferromagnetic and
non-magnetic conductive layers.83 The 2007 Nobel Prize was awarded to Albert Fert and
Peter Grunberg for the discovery of GMR where the main application of GMR is a
magnetic field sensor that is used to read data in hard disk drives, biosensors,
microelectromechanical systems and other types of devices.72
Magnetoresistance (MR) occurs when the electrical resistance of a material
changes when a magnetic field is applied to this material.73When an electromagnetic field
is applied, the magnetic moments of the different magnetic compounds align with respect
to each other and their magnetizations are parallel. This increased alignment/polarity
leads to an actual decrease or drop in electrical resistance of the material due to the
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organizational or uniform spin of the molecules.73 The MR and/or GMR are initiated
from the interaction of the current carrying the electrons and the magnetization of the
host magnetic material.73 When electrons have not been exposed to a strong magnetic
field, the spin-dependent electrons are often scattered and spinning with no organization
or without the unity of direction that is derived from polarity. In the presence of a
magnetic field, the spin-dependent electron scattering within the substance will be
reduced and the electrical resistance will decrease once order is established in the
organized and unified directional spin of the electrons.73 The parallel (ferromagnetism)
and the anti-parallel (anti-ferromagnetism) spin induced by the nickel and chromium in
solution will ultimately order the electrons to spin in a bi-directional fashion. This
parallel/anti-parallel spin greatly increases the effectiveness and the strength of the
magnetic field.82 While GMR has been historically applied to solid state materials, many
chemical, biological, and biophysical reactions occur in liquid environments.73 The chips
or biosensors that are often used in these processes are microfluidic devices. These
biosensors are used to detect a bioanalyte’s ability to possess biological recognition of a
component that acts as a transducer that can measure an electrical output signal.73 Bruce
Lipton has referred to the cell membrane as an actual microchip that can be considered to
have the properties of a liquid crystal semiconductor with gates.6 The DNA can be
considered to be an electromagnetic antennae which is a powerful receiver, transmitter
and amplifier of frequencies.6 All of these concepts combined with water being the major
component of life leads to a possible application of magnetism and water as being a
powerful driver of many chemical and electrical mechanisms in living organisms.
Our in vitro experiments have been conducted with a hypotonic saline solution
that is exposed to diamagnetic (copper), ferromagnetic (nickel), anti-ferromagnetic
(chromium) and paramagnetic (sodium and molybdenum) metals that are known
components of the stainless steel and copper rings in the CETS module, in the presence
of a magnetic field. A possible hypothesis is that the theoretical parallel and anti-parallel
spins of the ferromagnetic and anti-ferromagnetic metals could offer a decreased bidirectional resistance and increased efficiency in the membrane allowing the membrane
to be more easily gated in order to conduct more work of the cell. In other words,
ferromagnetic materials retain highly ordered magnetic states when magnetic moments
are aligned in the presence of a field.4 The Lorenz force and the right hand rule can be
used to explain how the electrons will react and the directional movement or the spin they
will exhibit in relation to the magnetic field and the applied charge.80 The Lorenz force is
a force that is exerted by a moving external electric field (E).80 The force (F) or direction
of the spin will always occur perpendicular (either up or down) to both the velocity (v) of
the charge (q) and the magnetic field (B) (Equation 2).
F = q (E + v x B)

Eq. 2

To further explain the ferromagnetism and anti-ferromagnetic spins of the nickel
and chromium in the presence of a magnetic field, the ferromagnetic metals spin would
travel upwards and the anti-ferromagnetic spin would travel downward. If the charge is
applied in the same direction as the magnetic field, then the magnetic field will be zero
and non-existent.85 Magnetic fields are very different from electric fields in that they exist
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only in a three-dimensional fashion. The units of a magnetic field are Newton seconds
(Coulomb meter) or Newtons per Ampere meter. This unit is named the Tesla.84
Metal Ions in Aqueous Solution and Proteins
In aqueous solutions, the water molecules that are attached to the metal ions are
classified as belonging to the first coordination sphere or the first shell.86, 87 The first
sphere refers to the central atom or ion and the array of molecules or anions that are
attached around with a dative covalent bond.86,87 The second coordination sphere includes
molecules that are attached non-covalently to the ligands by hydrogen bonding.86,87 When
metal ions are in aqueous solution they are called aqua ions. Aqua ions are in most
natural waters and are major constituents of seawater. Interestingly, blood also has
concentrations of aqua ions similar to seawater.87,88,89 When one examines the two
coordination spheres of the aqua ion, it is known that the second coordination sphere is
essential in understanding the reactions of this metal complex (metal ion and water)
because this second complex consists of hydrogen bonding and is involved in
mechanisms of ligand exchange and catalysis.87,89 These aqua ions play a role in the
building of many intracellular proteins by serving as a coenzyme or cofactor.
Metalloproteins are proteins that contain a metal ion cofactor or coenzyme.90,91 A large
number of proteins fall into this category. It has been estimated that half of all proteins
contain a metal, while one third of all proteins may also require metals to carry out their
functions.90 Metalloproteins have been associated with storage and transport of proteins,
enzymes and signal transduction proteins.90
Due to the relatively unknown and poorly understood mechanisms that could be
occurring in the water to lead to these interesting experimental effects, we will discuss
the different water analyses we conducted and the metal ion changes we found between
the 3mM hypotonic saline solution that had been treated with the CETS unit as compared
to the control. The various aqueous metal ions that were found are known to have
differing magnetic properties. These aqueous metal ions and their known magnetic
differences became the basis for our experiments in this chapter.
METHODS
Water Analysis of Metal Ions
In order to determine the basis for the biological effects induced by the CETS
system, we examined the ionic composition of the water before and after treatments and
after filtering of the treated water by performing a water analysis (Table 5). Eight liters
of de-ionized water were placed in a 12 liter foot tub plastic wash basin and 5.5 ml of 5M
NaCl were added from which 500 ml were removed and placed in a clean plastic
container to serve as the ‘control’ saline solution (per request of A & L). The CETS
module was then placed in the plastic wash basin and 2.0 amps of current applied for 30
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Table 5.

Analysis of CETS-Treated and Untreated Dilute Saline.

Control
(Unfiltered)
Ion/Element
Concentration
Chloride
205 mg/L
Chromium
1.13 μg/L
Copper
4.89 μg/L
Iron
<100 μg/L
Lead
<0.5 μg/L
Molybdenum
<1 μg/L
Nickel
<0.5 μg/L
Sodium
128 mg/L
Titanium
<1 μg/L
*NR-none registered/measured.

Treated
(Unfiltered)
Concentration
128 mg/L
22.7 μg/L
1600 μg/L
<100 μg/L
<0.5 μg/L
2.58 μg/L
12.1 μg/L
82.8 mg/L
<1 μg/L
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Treated
(Filtered)
Concentration
*NR
18.8 μg/L
2.69 μg/L
<100 μg/L
<0.5 μg/L
2.4 μg/L
7.49 μg/L
83.3 mg/L
<1 μg/L

minutes. Next, 500 ml of the ‘treated’ saline solution was removed and placed in a clean
plastic container. A separate 500 ml of the ‘treated’ saline solution was run through a
0.45 micron filter and placed in a clean plastic container. The three containers of the
control, treated and treated-filtered saline solution were immediately transported for the
water ion analysis to A & L Analytical Laboratories in Memphis, TN.
Comparison Water Analysis with Metal Ions
In order to determine if the biological effects induced by the CETS system could
be replicated without running DC through the CETS system and by simply adding the
metal salts noted in the first water analysis in Table 5, we examined the ionic
composition of the water before and after adding the metal salts to the same
concentrations (treated) and after filtering of the metal salt water (treated filtered) (Table
6). Eight liters of de-ionized water were placed in a 12.6 liter foot tub plastic wash basin
and 5.5 ml of 5M NaCl were added. Then the microgram/liter concentrations of
molybdenum, chromium and nickel were added to the 3mM hypotonic saline solution.
Then 500 ml were removed and placed in a clean plastic container and 500 ml were
removed and run through a 0.45 micron filter (Corning) and placed in a clean plastic
container. The filtered and unfiltered saline/metal salt solution were immediately
transported for the water ion analysis to A & L Analytical Laboratories in Memphis, TN.
Cell Growth with Metal Salts
We cultured B16, L929 and MDA-MB231 cells in the DMEM-10 with media that
was reconstituted with a hypotonic saline solution that had chromium, nickel and
molybdenum salts added to the same concentrations as found in the water analysis (Table
6) and the control groups of each of the three cell lines were cultured in media that was
reconstituted with the same hypotonic saline solution that had not been treated with the
CETS system (See Chapter 2). The treated group of MCF-10A cells was cultured in the
DMEM/F12-5 media that had been reconstituted with a hypotonic saline solution that had
chromium (Aldrich Chromium (111) chloride hexa-hydrate, lot # BCBM86667V), nickel
(Sigma Nickel (11) chloride hexa-hydrate, lot # 054M0001V) and molybdenum (Aldrich
Molybdenum powder, lot # MKBT3128V) salts added to the same concentrations as
found in the water analysis (Table 5) and the control group was cultured in media that
was reconstituted with a hypotonic saline solution that had not been treated with the
CETS system. On day one, aliquots of 10,000 cells were plated in three 6-well plates for
each of the two groups in each of the four cell lines. They were plated in their standard
DMEM-10 or DMEM/F12-5 media on day 1. On day 2, the treated (n=18) and control
(n=18) media for each of the four cell lines were made and the original standard media
was replaced in each of the wells with the newly prepared treated and control media. On
days 3 through 7, wells from the control group and treated group of each cell lines were
trypsinized, removed from 3 wells of each group and counted using a Scepter Automated
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Table 6.
Comparison of Metal Ions in CETS Treated Filtered and Metal Salt
Filtered Water.
Ion/Element
Chloride
Copper
Chromium
Nickel
Sodium
Molybdenum

Magnetism
Diamagnetic
Diamagnetic
Anti-ferromagnetic
Ferromagnetic
Paramagnetic
Paramagnetic
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CETS Treated
↓ 100%
↓99%
↓17%
↓38%
↓00%
↓06%

Metal Salts
↑33%
Not added
↓32%
↓02%
↑21%
↓58%

Cell Counter (Millipore). Remaining wells had the control and treated media replaced
daily.
Cell Growth with Autoclaved CETS Treated Water
We cultured the treated MDA-MB231 cells in the DMEM-10 with media that was
reconstituted with a hypotonic saline solution that had been treated with the CETS system
for 30 minutes and was then placed in the autoclave at 120o C for 40 minutes prior to
making the growth media and the control group was cultured in media that was
reconstituted with the same hypotonic saline solution that had not been treated with the
CETS system and autoclaved. On day one, aliquots of 10,000 cells were plated in three 6well plates for each of the two groups. They were plated in their standard DMEM-10
media on day 1. On day 2, the treated (n=18) and control (n=18) media for each of the
four cell lines were made and the original standard media was replaced in each of the
wells with the newly prepared treated/autoclaved and control media. On days 3 through
7, wells from the control group and treated group were trypsinized, removed from 3 wells
of each group and counted using a Scepter Automated Cell Counter (Millipore).
Remaining wells had the control and treated media replaced daily.
Cell Growth with CETS Treated Water and Magnet
We cultured the MDA-MB231 cells in the DMEM-10 with media that was
reconstituted with a hypotonic saline solution that had been treated with the CETS system
for 30 minutes and was then placed in test tubes that were placed next to a magnet for 24
hours prior to making the growth media and the control groups were cultured in media
that was reconstituted with the same hypotonic saline solution that had not been treated
with the CETS system and had been both exposed to magnet and not exposed to magnet.
On day one, aliquots of 10,000 cells were plated in three 6-well plates for each of the two
groups. They were plated in their standard DMEM-10 media on day 1. On day 2, the
treated (n=18) and control (n=18) media for each of the four groups were made and the
original standard media was replaced in each of the wells with the newly prepared
treated/magnet and control/magnet media. On days 3 through 7, wells from the control
group and treated group were trypsinized, removed from 3 wells of each group and
counted using a Scepter Automated Cell Counter (Millipore). Remaining wells had the
control and treated media replaced daily.
RESULTS
Metal Ions in the CETS treated Water Analysis
Analysis of water samples found differences in chromium, copper, molybdenum,
nickel and sodium between treated samples and control (Table 6). In the control water,
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there is a measurable concentration of chloride, chromium, copper and sodium. The
chloride and sodium can be attributed to the addition of the molecular grade NaCl to the
de-ionized water. The chromium and copper are either naturally in the water or are
deposited from the water pipes etc. The treated water prior to filtering through a 0.45
micron filter for sterilization with the in vitro experiments, contains more chromium,
copper, molybdenum and nickel and less sodium and chloride than the control. After
filtering the treated water, the majority of the chromium, molybdenum, nickel and
sodium remains, while the copper and chloride appear to be retained by the filter.
Metal Ions in Metal Salt Water Analysis
When examining the results of the metal salt water analysis, chloride does not
remain in solution with filtering after exposure to the magnetic field from the CETS
system. Chloride does remain in solution after the water is reconstituted with the metal
salts. Copper also does not remain in solution after filtering once exposed to the magnetic
field of the CETS system. These are both diamagnetic metals. Chromium is an antiferromagnetic metal and the data suggest it remains in solution at a higher concentration
after exposure to a field than when added as a metal salt. Nickel is a ferromagnetic metal
and appears to remain in solution in higher levels when added as a metal salt as opposed
to when exposed to the magnetic field of the CETS. Sodium and molybdenum are
paramagnetic metals and appear to remain in solution in higher concentrations once
exposed to the magnetic field of the CETS system.
Cell Growth with Metal Salts
To determine if the growth inhibition was due to the metals that are found in the
treated filtered water, growth media was made with control water with the same
concentrations of chromium, molybdenum and nickel salt that was made to correspond to
the same concentrations as noted in the water analysis of the treated filtered water. We
found that the doubling time in the metal salt supplemented media has the opposite effect
seen with the CETS treated water (Figure 27) e.g. the cells grew at the same rate equal to
that of the non-treated control media.
Cell Growth with Autoclaved CETS Treated Water
To determine if heating the water would change the effects of the treated
water/media on the growth inhibition, we autoclaved treated water autoclaved at 120o C
and 1.1 bars for 40 minutes prior to making the media to see if it would have a
differential effect on the growth of cancerous cells compared to non-autoclaved water.
We did not observe a change in the appearance (e.g. color, precipitate etc.) in the
autoclaved treated water. We then plated the human breast carcinoma and prepared and
changed the media daily over 6 days. The doubling times suggests the effects are negated
with heating the treated water (Figure 28). The heating of metal aqueous ions affects the
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Figure 27.
Metal Salt Experiments.
A 3mM saline solution that was identical to the solution used in all the previous
experiments was made. Instead of treating with the CETS system, nickel, chromium and
molybdenum salts were added to the hypotonic saline solution in order to achieve their
same concentrations as found in the CETS treated-filtered water by the analysis of an
independent laboratory. All four cell lines were cultured in standard media and the
control and metal salts media were added to the wells on Day 2 and the media was made
and replaced daily. Wells were also counted in triplicate daily. Data were analyzed with
unpaired two-tailed t-tests.
(A) Murine melanoma; mean control 385536.2; mean treated 973811.4; df = 40;
ts =-2.21586; p = 0.032455. (B) Murine fibroblasts; mean control 295167.1; mean treated
583794.8; df = 40; ts = -2.13383; p = 0.03904. (C) Human breast carcinoma; mean
control 319071.4; mean treated 446895.2; df = 40; ts = -0.98762; p = 0.329275. (D)
Human epithelial cells; mean control 65259.52; mean treated 78675.19; df = 40;
ts =-0.54548; p = 0.588451.
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Figure 28.
MDA-MB231 Cell Autoclave Experiment.
MDA-MB231 cells plated in media made with treated CETS saline after autoclaving.
Data were analyzed with unpaired t-tests; mean control 659690.5; mean treated
571904.8; df = 40; ts = 0.433124; p = 0.667251.
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magnetic behavior of these metal ion complexes and is known to exhibit this phenomena
from 25o C and 1 Bar to 5000oC.28 The data suggests that heating in the autoclave to
120oC and 1.1 bar could be leading to a change in the magnetic behavior of the metal
aqueous ions thereby negating their effects.
Cell Growth with CETS Treated Water and Magnet
To determine if the effect is due to magnetism, we hypothesized that treated water
exposed to the magnet for 24 hours prior to making the media would have a differential
effect on the growth of cancerous cells compared to the control water exposed to the
magnet for 24 hours. We exposed both control and treated media placed in a test tube to a
magnet. We found that there was a significant difference between the treated group
exposed to the magnet and the treated group that was not exposed to the magnet, while no
difference in the growth was noted between the control groups when the control water
was exposed or not exposed to the magnet (Figure 29). This suggests the CETS induced
effect in the water that has contributed to growth inhibition, cell cycle arrest, membrane
potential change and genomic effects noted in our experiments is affected by exposure to
another magnetic field and this field was generated by the magnet.
DISCUSSION
The CETS system uses a Lorenz force with DC that is applied through a cathode
and an anode in a perpendicular fashion to a set of metal rings that consists of
diamagnetic, paramagnetic, ferromagnetic and antiferromagnetic metals. These rings are
placed in water where they create an electromagnetic field in the presence of this current.
The copper or diamagnetic ring sits in the center of the stainless steel rings which
separates the field traveling through the anode and cathode pathways and helps to create
the perpendicular field to the current. Lorenz force is being produced by current being
applied in perpendicular fashion to the magnetic field. The persisting and possible
permanent change in the ferromagnetism and its associated parallel spin that is displayed
by the nickel, and the change in the anti-ferromagnetism and its associated anti-parallel
spin that is displayed by the chromium, leads to the increased strength of the magnetic
field (GMR) and organizational polarity. These concepts suggest that it is possible that a
magnetic change in the saline/metal ion solution is being induced by applying an
electromagnetic field to these metals in the presence of this water. Since ferromagnetism
persists in the absence of a field, this would suggest that the parallel spin (nickel) and
anti-parallel spin (chromium) of electrons would persist in the growth media (that was
made with the treated hypotonic saline solution) when it is used to grow the cancerous
and noncancerous cells in vitro in our experiments. The bi-directional spin of metal ions,
induced by a strong parallel, anti-parallel spin of the magnetic metals, could decrease the
electrical resistance in the cell membranes that is exhibiting increased electrical
resistance due to the lack of ordered spin that could be occurring in the depolarized
cancerous and/or proliferating cells. This cell membrane or microchip is known to be
gated with cell signaling mechanisms and it is known to carry a charge.8 The organized
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Figure 29.
MDA-MB231 Magnet Experiment.
Control magnet exposed and non-magnetic exposed water was used to make the growth
media. This suggests the CETS induced effect in the water that has contributed to growth
inhibition, cell cycle arrest, membrane potential change and genomic effects noted in our
experiments is affected by exposure to another magnetic field and this field was
generated by the magnet. Data analyzed with unpaired t-tests and showed no significant
difference in growth; control magnetic exposed mean 659690; control non-magnetic
exposed mean 571904.8; ts = 0.781225; df = 40; p = 0.43927. Treated magnet-exposed
and treated non-exposed showed a significant difference in growth; treated magnetic
exposed mean 145748.6; treated non-magnetic exposed mean 41152.38; ts = 2.61961;
df = 40; p = 0.012379.
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nature of the magnetic resistance could in fact be decreasing the electrical resistance and
allowing a more organized flow of ions through the liquid crystal semiconductor
membrane. Movement of charges due to lateral diffusion within a plasma membrane is
essentially a rotating magnetic field.97 The parallel and anti-parallel spins, as well as the
accompanying paramagnetic changes in organizational spin, could offer a decreased bidirectional resistance in the membrane, allowing the membrane to be more easily gated in
order to conduct more work of the cell. These metal ions that are formed after exposure
to the electromagnetic field that is applied to the hypotonic saline solution by the CETS
system may also be a factor in protein synthesis in the intracellular matrix due to the
interaction with the cell membrane. The charged ions could possibly be developing dative
covalent bonds with the water molecule in the presence of the electromagnetic field in the
first coordination sphere.92,93,94 These bonds create the spins that are known to occur with
the magnetism of the specific metals. This will then offer an opening for second
coordination sphere non-covalent hydrogen bonding that can lead to the development of
metal ion cofactors that can be used for the initiation of protein synthesis.92,93 A major
site of the interaction of a divalent metal ion and a nucleotide has been shown to be
between the cation and the phosphate chain.77 A major complex of divalent cations and
nucleotides is known to consist of ATP.77 There is an interaction of divalent ions with the
ring of nitrogen atoms in nucleotides and this interaction has been studied with the use of
paramagnetic and ferromagnetic ions showing significant changes in the proton magnetic
resonance spectra of these nucleotides. 92 It has also been noted that complexes of
magnesium (paramagnetic) with nitrogenous ligands are considerably weaker than the
complexes of nickel (ferromagnetic) and this corresponds to the strength of the
magnetism associated with these metal ions.77, 24 The factors that govern metal binding
affinity and selectivity in proteins range from: 1) intrinsic properties of the metal, 2)
primary coordination sphere, 3) secondary coordination sphere, 4) protein matrix, 5) bulk
solvent, 6) competing non-protein ligands from the surrounding biological environment.95
Once the field is created and the metal ions begin to attach to the water molecules in the
first coordination sphere, they can then also begin to interact with the cell membrane and
become a possible cofactor or catalyst for the initiation of metalloproteins in the
membrane proteins and intracellular matrix through hydrogen (non-covalent) bonding
that occurs in the second coordination sphere.89
The differing concentrations of the different metal ions that remain in solution
after the filtering process once they have been exposed to the magnetic field by the CETS
system, when compared to the concentration that remain in solution after the addition of
the metal salts, could be a possible mechanism that may have a magnetic basis. When the
treated water that contained the metal ions was immediately heated in an autoclave, our
experiments show this heating decreased the growth inhibitory effect of the treated
media. The growth inhibitory effect was also decreased after the treated water was
exposed to a magnet and its magnetic field prior to making the growth media for
culturing. The growth inhibitory effects was also reduced once the media was made with
the treated water while the treated water appears to hold the effect when left unexposed to
high temperatures, other magnetic fields and other metal ions. We know that the
magnetic properties of metal ions are sensitive to temperature and magnetic fields.96
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CONCLUSION
The concept of magnetic drug targeting has been around for over 30 years and
magnetic nanoparticles are a class of engineered particulate materials of <100nm that can
be influenced or manipulated by an external magnetic field.79 Targeting of drugs by
nanoparticles is intended to decrease drug waste, frequency of administration, reduce side
effects, and increase sustained delivery to desired organ target.74 There has been limited
success due to magnetic forces generally being short ranged and underwhelming to the
hydrodynamic forces in the body.74,79 Magnetic nanoparticles consist of magnetic
compounds, such as iron, nickel, cobalt and their oxides. My experimental data suggest
significant effects on cell growth, cell cycle, membrane potential, cell migration and
genomic expression with the CETS treated water. Could the electromagnetic field be
inducing a modulation in the magnetic structure of the water? When one examines these
metal ions that remain in the treated-filtered water, the concentrations of these metal ions
(chromium, nickel, sodium and molybdenum) is strikingly similar to their concentrations
in seawater and blood. These similar concentrations make an interesting correlation to the
concept of how we are connected to the naturally occurring water that is said to be the
‘staff of life.’
The effects in our experiments appear to also be differentially expressed with the
observations of growth inhibition of cancerous cells and lack of growth inhibition in
noncancerous cells. Increased cell migration was also observed in the mouse fibroblasts
with wound care data which shows an application for wound healing. Quantification of
the possible magnetic nanoparticle effects, if any, warrant further investigation. The
CETS system could offer a form of magnetic nanoparticle augmentation that utilizes a
hypotonic saline solution that is exposed to a carefully designed set of metal rings in the
presence of an electromagnetic field and that produces metal aqueous ions that interact
with the cell membrane and significantly affect cell behaviors. Due to the fact that the
addition of the metal salt/ions to exact molar concentrations found in the treated filtered
water analysis did not yield the same differential cell growth results in our laboratory
experiments; the data suggest the metal ions may only form a divalent covalent bond in
water in the presence of an induced electromagnetic field. Therefore, DC, metal rings,
water (with ions) and electromagnetic field may be all needed to produce the aqueous
metal ion solution that is needed to achieve the biological effects noted in these
experiments and quite possibly in the anecdotal reports that have occurred across the
globe over the last 20 years with use of the CETS system. When we review the
susceptibilities or criteria for inducing magnetic moments into materials, they are:
temperature, external field H and atomic structure. The in vitro experiments were
conducted with an aqueous solution that had previously been exposed to the external field
H but was not actively present during the cell culturing and growth phases. We also
conducted these experiments after exposing the treated aqueous solution to high
temperatures of the autoclave. It is known that at sufficiently high temperatures (blocking
temperature) thermal energy is the catalyst that induces free rotation of the particle
resulting in a loss of net magnetization in the absence of an external field.78 The data
suggest that the metal ions are only catalysts or cofactors for metalloproteins, when they
are formed in the presence of current through a magnetic field in the medium of water. If
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these metal ions are forming covalent bonds, the dissociation of these bonds explain the
nullification of the effects seen with heating the treated water in the autoclave due to the
high temperature negating effects. Lastly, the exposure of the treated water to the
magnetic field of the magnet also appeared to reduce the effects of the treated water on
the cell growth. If magnetism was involved in the effects seen in our experiments, then
the exposure to a field could be a factor in influencing the directional spins induced by
the CETS system. These results suggest our experiments may be possibly showing effects
that are known to exist in the magnetic nanoparticle world but have remained elusive in
their application for health. Due to the fact that the CETS has shown many anecdotal
health benefits across the globe and that this work is showing significant experimental
effects that appear to correspond to these phenomena, future research into responsible
mechanisms are warranted.
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CHAPTER 5.

DISCUSSION

These experiments have been conducted in this dissertation research to test
whether there are differential growth effects when cancer cells are maintained in media
reconstituted with the water treated by the CETS system. Experimental data showed
cancerous cell growth inhibition while not affecting noncancerous cell growth. This
cancer cell growth inhibition also showed cell cycle arrest, hyperpolarization of plasma
membranes, annexin staining and genomic upregulation of ER stress/UPR as well as the
p53 oncogene. This CETS treated water analyses also suggests a possible modulation of
the magnetic behavior of metal aqueous ions.
Our experiments show a correlation to the Rogerian theoretical framework that
suggests that bioelectrodynamics can utilize an electrical energy source that affects not
only the organism but the field immediately surrounding the organism. The tertiary
interaction of these three components: 1) energy source (DC), 2) environment (water),
and the 3) organism (cells) are all involved in the process of bioelectrodynamics. This
data gives quantitative measurements of a previously abstract concept that has often
failed to obtain data that is readily accepted by the scientific community. The microarray
and genomic validations revealed some interesting results that while unexpected, show
some interesting possibilities for future work with many chronic co-morbidities. The
UPR is linked to many chronic co-morbidities in the literature that include but are not
limited to: cancer, hyperlipidemia, allergies, asthma, COPD, cystic fibrosis, autism, ALS,
Parkinson’s disease, Huntington’s disease, organ fibrosis, diabetes and many more.
Proteins must be folded in appropriate fashion in order to be able to be used by the cell
and ultimately an organism. It has been estimated that if we took a penny to represent
every cellular protein, it would fill up the Pacific Ocean with these pennies. The number
of proteins a cell must properly fold is vast. If the proteins are not properly folded, this
can lead to toxicity in the cell/organism. Cancer cells hijack the UPR and exploit the
pathway in order to survive and avoid programmed cell death. Neurons in the brain enter
into programmed cell death when unfolded proteins begin accumulating in patients
leading to amyloid fibrils that contribute to the development of the neurodegenerative
diseases of ALS, Parkinson’s disease and Huntington’s disease. Many allergies are
caused by an incorrect folding of some proteins leading to a failure of the immune
system’s production of antibodies for certain protein structures. Misfolding and excessive
degradation of proteins are linked to cystic fibrosis and lysosomal storage disease. Our
experiments show that external factors of high temperatures of the autoclave and external
fields (electric, magnetic), have an effect on protein folding. Folding is a process that can
require ATP energy for recruitment of chaperones or occur spontaneously with inputs
from the nucleoside triphosphates. The folding of proteins is believed to be enhanced by
intramolecular hydrogen bonds and is opposed by an energy deficit. In theory, the
hyperpolarization of the cell membrane in our experiments could be reducing factors that
lead to ER stress and problems with protein folding. The genomic analyses with the
MDA-MB231 and MCF-10A cells suggest that a change in the magnetic behavior of the
aqueous metal ions may prevent the cancer cell from hijacking the UPR for survival. The
data from the genomic analyses from the MCF-10A cells also suggests that it may help
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relieve the ER stress and therefore prevent programmed cell death in noncancerous cells.
Also, the upregulation of Amphiregulin (AREG) in the MCF-10A cells microarray could
offer a genomic link to spark wound care clinical trials. The TNFRSF9 gene upregulation
could help with the internal immune response activation in the fight against the
cancerous, inflamed and injured cells.
Magnetic nanoparticle therapies have been widely used in drug delivery and
hyperthermia treatments for cancer. Recent applications of magnetic nanoparticles have
shown great promise towards decreasing infections and tissue growth. To continue to
build this science, much future research is warranted in order to translate this application
more fully to mainstream medicine.98These magnetic nanoparticles have been used to
augment chemicals that are foreign to the body. When one looks at the building block of
the body, the cell, it is known that they are composed of water, inorganic ions and
carbon-containing molecules. Water is the most abundant molecule in cells. Therefore,
our understanding of water and the other constituents and how they act and interact
together are paramount in the study of biology. Because of the polar nature of water
molecules, they can form hydrogen bonds with both other polar molecules and well as
with positively and negatively charged ions. The study of proteolysis could also provide
answers to the wide range of conditions under which this protein folding could be
analyzed. Water may be the essential component to bridge the magnetic nanoparticle
world to living organisms that warrants further experimental testing. Chapter 4 delves
into the key components of the water structure that undergo change with the CETS
treatment. We have much to learn about how these magnetic ions and their solubility and
other behavioral changes in the CETS treated water are actually driving or changing the
behavior of the cells with regards to cell growth, cell migration, cell cycle progression,
cell size, membrane potential, cell death and genomic level changes. The mechanisms
may be occurring quickly and in multiplicity and will take many experimental studies to
begin to piece together the puzzle as to how these cellular behaviors become so
significantly altered.
Cancer will affect one in three individuals over their lifetime. Drugs that treat
cancer and wounds are so expensive, the costs are affecting the care of patients with these
chronic co-morbidities and our health care system.99 Mayo Clinic recently introduced
seven actions that could reduce the cost of cancer drugs and improve the ability for
patients to receive adequate treatment. One action they considered is allowing the
Patient-Centered Outcomes Research Institute-which the Affordable Care Act initiatives
created to evaluate the benefits of new treatments. They recommend similar organizations
include pricing in their assessment of treatment value. The financial burdens placed on
the health care system for treatment of cancer and wounds have to be addressed as we
progress into future options for these patients. The CETS system can offer an adjunct that
is affordable to our health care system. It appears that CETS system needs to be taken to
both animal models and to clinical trials to evaluate the effectiveness of this as a future
adjunct treatment for cancer, wounds and other chronic co-morbidities. We have seen the
toxicity and failure of many current cancer and wound care treatments for decades. When
done in combination with chemotherapy and radiation, the upregulation of both UPR and
the JMY/p53 oncogene by the CETS treated water could help decrease the toxicity of
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these treatments allowing for the patients to complete the standards of care that are
currently FDA approved and in oncological practice. Clinical trial testing with the CETS
system could offer hope and improved outcomes to mankind.
We have a phase 1 safety trial for the CETS system approved by the UTHSC IRB
and will be conducting the study in early 2016. This safety trial along with the
experimental data and case study data we are collecting from anecdotal reports, will
provide critical and essential data that could allow the CETS system to be used in patients
in the areas cancer and wound care and lay the foundation for additional studies in other
chronic co-morbidities that are connected to the UPR. These actions could help lead to a
future paradigm shift in how we address life, health and wellness. There are many policy
obstacles to overcome in the future in order to bring this device to market. Due to the
transition from a Newtonian Physics based application to a quantum physics based
application of the CETS system, great efforts will be needed to overcome provider bias
and skepticism. The experimental, animal models and clinical trial data will be critical to
establish the scientific basis in order to gain scientific credibility and validity. There will
also be obstacles to overcome that favor medication reimbursement for cancer therapies.
Ultimately all the stakeholders will need to see the safety, efficacy and profitability with
use of the CETS for future treatments in order for this to move forward in the
marketplace and for the benefit of mankind. Research funding is warranted for in order to
pursue the possibilities from the significant experimental, anecdotal and genomic results
presented in this work.
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